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T cell activation and thymic selection are thought to be determined by the binding 
propensity (avidity or affinity) of the T cell receptor (TCR) to its ligands. However, 
binding propensity quantified by previous 3D TCR–pMHC kinetics such as using 
tetramer staining or surface plasmon resonance (SPR) under estimate TCR–pMHC 
interaction due to neglecting physiological conditions. Recent studies considering 
membrane contribution in TCR–pMHC interaction reported 2D kinetics and force 
regulated bond dissociation kinetics have better prediction to biological responses in 
CD8
+
 T cells. In this study, we further tested the findings in CD4
+





 (double-positive, DP) thymocytes. We analyzed TCR–pMHC interaction for a 
well-characterized panel of altered peptide ligands (APLs) on multiple transgenic mouse 
TCR systems. Using ultrasensitive 2D mechanical assays, in situ 2D kinetic 
measurements show better sensitivity than the SPR 3D kinetic measurements in gauging 
the ligand potency and thymic selection. Furthermore, force-regulated bond lifetime of 
TCR–pMHC interaction amplifies the discrimination in recognition of APLs and thymic 
selection. When force was applied to TCR–pMHC–CD4/8 bonds, two distinct patterns 
emerged: agonist/negative selecting ligands formed CD4/8-dependent catch-slip bonds 
where lifetime first increased, reached a maximum, then decreased with increasing force, 
whereas antagonist/positive selecting ligands formed slip-only bonds where lifetime 
monotonically decreases with increasing force. Our results highlight an important role of 
mechanical force in ligand discrimination and suggest a new mechanism for T cell 




CHAPTER 1  INTRODUCTION 
 How do T cells recognize subtle difference in TCR ligands, initiate distinct 
intracellular signals, and induce the appropriate T cell function? is the central question 
for T cell immunity and central tolerance. The context in which to answer this question 
includes the complexity of surface molecules on the cell membrane, and the following 
signaling events across the cell membrane and inside of the cells. Furthermore, T cells are 
constantly exposed to a physical environment by cell motility and/or cellular cytoskeleton 
activity. However, previous techniques used to characterize TCR–pMHC interaction only 
focus on TCR–pMHC binding in the extracellular domain of TCR–pMHC interaction 
which fail to incorporate other physiological components such as co-receptor contribution 
and force regulation. In this study following objectives, central hypotheses, and specific 
aims are proposed to better investigate T cell recognition mechanism using an 
ultrasensitive 2D mechanical assays.   
1.1 Objectives 
 The main objective of this study is to better characterize in situ TCR–pMHC 
interaction with considering cellular component contribution, membrane restriction and 
physical force contribution to correlate with cellular function. Therefore, the central 
hypothesis of this thesis is co-receptor and force regulated 2D TCR-pMHC interaction 
determine T cell function. In order to fulfill the objective, three specific aims are 
performed with working hypotheses to test the central hypothesis.   
1.2 Aims and hypotheses 
Aim 1. Study 2D kinetics of TCR–pMHC interaction under force in an MHC class 
II system. 
 The working hypothesis for this aim is that in situ 2D kinetics and force 
regulation of TCR–pMHC interaction better define T cell response than previous 3D 
 
 2 
methods in MHC class II system. This hypothesis is based on the recent report that 
observed 2D kinetic measurement of TCR–pMHC in MHC class I system which 
suggested 2D kinetic results are more relevant to predict the T cell response
1
. In addition, 
since T cells are continuously in physical environment we hypothesize that force 
regulation could be critical in TCR–pMHC interaction. The rationale for testing this 
hypothesis is that it will provide more strong evidence for the importance of 2D kinetic 
measurement and force contribution in TCR–pMHC interaction by testing an MHC class 
II system which may or may not show difference to the MHC class I system. For testing 
the hypothesis, we quantified 2D kinetic parameters of 3.L2 TCR to analogues of Hb68-76 
ligand bound MHC II in naïve T cells to better predict the T cell response. We compared 
2D and 3D measurements to confirm the differences and the advantage of 2D kinetic 
parameters. Lastly, we analyzed force regulation in TCR–pMHC interaction for T cell 
response.  
 
Aim 2. Compare 2D kinetics of TCR–pMHC interaction and co-receptor 
cooperativity between naïve T cells and thymocytes.  
 The working hypothesis for this aim is that contribution of co-receptors and 2D 
kinetics may differ between naïve T cells and thymocytes. This hypothesis is based on 
previous studies that report co-receptor dependent increased thymocytes sensitivity
2-4
. 
Since T cell function and TCR expression differ during T cell maturity, we hypothesize 
TCR–pMHC interaction and co-receptor contribution may develop based on their 
maturation states. In order to test this hypothesis, we quantified and compared 2D kinetic 
parameters of 3.L2 and OT-I TCR binding to its respective APLs in naïve T cells and 
thymocytes. We compared the contribution of co-receptors in TCR–pMHC interaction 
for these systems. Lastly, we measured intracellular calcium signaling to compare the 




Aim 3. Study 2D kinetics of TCR–pMHC interaction under force for thymic 
selection.  
 The working hypothesis for this aim is that in situ 2D kinetics and force 
regulation of TCR–pMHC interaction better define thymic selection. This hypothesis is 
also based on the recent report that showed the importance of 2D kinetic measurement of 
TCR–pMHC in MHC class I system
1
. In addition, thymocytes are continuously moving 
and scanning in thymus encountering cortical (cTEC) and medulla thymic epithelial cells 
(mTEc)
5
 that may expose a physical environment to TCR–pMHC interaction. Therefore, 
it is reasonable to suspect physical force could play an important role in TCR–pMHC 
interaction in thymic selection. The rationale for testing this hypothesis is that it will 
allow evidence for the importance of 2D kinetic measurement and may suggest force 
contribution in TCR–pMHC interaction on thymocytes. To test the hypothesis, we 
quantified zero-force 2D kinetic parameters of immature TCR–pMHC interaction for 
thymic selection. We analyzed force regulation in TCR–pMHC interaction for thymic 
selection. Lastly, we verified force regulation effect in thymic selection with endogenous 





CHAPTER 2  BACKGROUND 
2.1 T cell immunology 
2.1.1 T lymphocytes 
 T lymphocytes are a type of lymphocytes or white blood cells that are 
distinguished from other lymphocytes by the presence of T-cell receptor (TCR) on their 
membrane surface. The name “T lymphocytes” are derived from an organ that these cells 
get matured in, a thymus which starts with alphabet “T.” T lymphocytes hold delicate 
mechanism in adoptive immunity as the last barrier of defense to pathogenic or viral 
invasion in human body. Current understanding of how T lymphocytes accomplish their 
adequate function in the immune system is fascinating but still insufficient. Clinical 
studies have shown that many immunodeficiency diseases, autoimmune diseases and 
transplant failures are due to malfunctioning and misunderstanding T cell immunity
6-8
.  
 Lymphocytes first derive from lymphoid progenitor (one of the differentiated cell 
type from stem cells) in bone marrow through process called “lymphopoiesis”
9
. Some of 
these lymphocytes stay in the bone marrow to be differentiated to B lymphocytes and 
some migrate to the thymus to undergo development to be T lymphocytes. These 
lymphocytes in the thymus are called thymocytes and they undergo multiple stages to 
fully develop TCR, get positively selected base on their TCR binding with self antigens, 




 naïve T cells
10, 11
. When fully 
maturated, naïve T cells now enter the circulation and peripheral lymphoid organs such as 
lymph nodes or spleen to perform their immunological activity. Most of them will 
monitor antigens expressed by pMHC on antigen presenting cells (APCs) for survival 
(i.e., immunological tolerance) or/and activation cues. Once they are exposed to a 
pathogenic antigen, these naïve T cells become effector T cells and undergo clonal 
expansion. The effector T cells will function as either releasing cytotoxic granule to kill 
 
 5 
the specific cells directly (CD8
+
 cytotoxic T cells) or releasing cytokines to trigger other 




. After their activity they 
become memory T cells and reside in the body. Like such, throughout the life of a T 
lymphocyte (Figure 2.1), exposure to an antigen, whether it is self-antigen or pathogenic, 
is critical in determining thymic development, central tolerance, and T cell immunity. 
Therefore, T cell recognition is important in both thymic development and T cell 
activation.  
 
Figure 2.1: Life of a T cell  
Thymocyte precursors enter thymus to undergo multiple stages of encountering cTECs 
and mTECs for thymic selection and lineage selection. When fully matured, T cells 
migrate to the periphery lymphoid organs constantly monitoring antigen on APCs. When 
pathogenic antigen is detected, naïve T cells undergo clonal expansion and become 
activated T cells and memory T cells.  
 
2.1.2 TCR/CD3 complex 
 TCR/CD3 complex plays an important role in differentiation, survival and 
function of T cells by engaging with pMHC (Figure 2.2). TCR is a heterodimer and the 
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two chains are linked by disulfide bonds. The extracellular portion is slightly less than 
10nm
9
. Each of the chain has N-terminal variable domain and constant Ig-like domain in 
the extracellular portion, followed by a transmembrane domain and a short cytoplasmic 
tail at the C-terminal end. At the variable domain, there is the complementarity 
determining region which binds with the pMHC
9
. There are two lineages of T cells 
depending on the heterodimer combination. About 95% of the T cells have αβ TCR and 
about 5% of the T cells have γδ TCR
9
. The TCR normally associates with invariant 
chains of CD3 complex compose of εδ and εγ heterodimers, and ζζ homodimer. This 
association is stabilized by polar interaction between CD3 molecules that have negatively 
charged transmembrane region and TCR that has positively charged transmembrane 
region
9
. Since TCR have short cytoplasmic tail that lack signaling domain, CD3 complex 
is critical in signaling cascade. There are 10 immunoreceptor tyrosine based activation 
motifs (ITAMs) in the cytoplasmic tail of CD3 heterodimersand ζζ homodimer that 





Figure 2.2: TCR/CD3 complex engaging with pMHCTCR is a heterodimer complexed 
with three dimers of CD3 which has 10 ITAMs in total for intracellular signaling. Once 
pMHC binds to TCR/CD3, Lck is brought to TCR/CD3 complex to phosphorylate 
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ITAMS allowing ZAP70 to bind and further initiate signaling cascade (adapted from 




2.1.3 Co-receptors CD4 and CD8 
 Along with TCR/CD3 complex, co-receptors CD4 and CD8 play important roles 
in the TCR–pMHC interaction. It is known that co-receptors bind also on the MHC 
molecule to bring Src family tyrosine kinase p56
lck
 or Lck to the TCR/CD3 complex to 
trigger the signaling cascades
9, 12, 13
. CD4 is a single chain glycoprotein that has 4 
immunoglobulin domains (D1, D2, D3, and D4). The D1 domain interacts with the β2 
domain of a MHC II molecule
14, 15
 and the cytoplasmic C-terminal end interacts with Lck 
molecules. On the other hand, CD8 is a αβ heterodimer transmembrane glycoprotein that 
have immunoglobulin variable (IgV)-like extracellular domain connected to the 
membrane by a thin stalk. The extracellular IgV-like domain of an α chain interacts with 
the α3 portion of a Class I MHC molecule and the cytoplasmic tail recruits Lck molecules 
to the TCR/CD3 complex. CD4 and CD8 are expressed on different subpopulation of T 
cells that have different functions. CD4 is restricted to an MHC class II expressed on T 
helper cells, and CD8 is restricted to an MHC class I expressed on cytotoxic T cells (or 





 TCR–pMHC interaction is the main initial event that leads to the specific T cell 
response
9
. MHC has two general classes depending on the components and the peptide it 
presents (Figure 2.3). MHC class I molecules consist of two polypeptide chains, α and 
β2-microglobulin that are linked non-covalently
9
. Among 3 domains in α chain (α1, α2, 
and α3), the α1 and α2 domain make a pocket to hold endogeneous antigen peptide that 
are cleaved by proteosome whereas the α3 is the site for CD8 binding. Normally the 
peptide that is presented by MHC class I molecule is 8-10 amino acids long
9
. On the 
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other hand, MHC class II molecules comprise of αβ heterodimers that have peptide 
binding pocket at the α1 and β1 domain. The peptides that are expressed by MHC class II 
molecules are exogeneous antigen fragments that are degraded in the endosome which 
are at least 13 amino acid residues long
9
. The β2 domain on MHC class II molecule 




Figure 2.3: Generation of pMHC class I and class IIFor MHC class I molecule, 
endogenous antigen fragment of 8-10 amino acids is presented by two polypeptide 
chains, α and β2-microglobulin. For MHC class II molecule, exogenous antigen fragment 
of 13 amino acids is presented by αβ heterodimers (adapted from Nankivell et al., N. 






2.1.5 Calcium mediated intracellular signaling 
 Once a pMHC get engaged to a TCR/CD3 complex, intracellular signaling 
molecules get involved to further direct the T cell response
17-22
. As TCR–pMHC 
interacts, CD4/CD8 co-receptors are recruited to form a synapse with the TCR–pMHC 
binding complex
17, 23, 24
. As this complex is formed, Src family tyrosine kinase Lck which 
is linked to cytoplasmic tail of the co-receptors get recruited to initiate the signaling. The 
Lck phosphorylates ITAMs on cytoplasmic domains of CD3s and ζ chains and allow a 
docking site for ζ‑chain-associated protein kinase of 70 kDa (Zap70) to bind. This 
initiates phosphorylation of adaptor proteins, such as Src-homology-2-domain-containing 
leukocyte protein of 76kDa (SLP76) and linker for activation of T cells (LAT). This leads 
to the recruitment and activation of the TEC kinase interleukin-2-inducible T-cell kinase 
(ITK) and phospholipase Cγ1 (PLCγ1). In addition, binding of G-protein-coupled 
chemokine receptors results in the activation of PLCβ. The PLCβ and PLCγ1 catalyse the 
hydrolysis of the membrane phospholipid phosphatidylinositol-4,5-bisphosphate 
(PtdIns(4,5)P2) to inositol-1,4,5-trisphosphate (InsP3) and diacylglycerol (DAG). The 
InsP3 binds to the InsP3 receptors (InsP3Rs) for the release of ER stored Ca
2+
. The 
decrease of stored Ca
2+
 in ER is detected by stromal interaction molecule 1 (STIM1), 
which in turn activates calcium-release-activated calcium (CRAC) channels in the plasma 




 influx through the activated CRAC channel, the 




 dependent enzymes, such as 
calcineurin, and thereby some transcription factors, such as nuclear factor of activated T 
cells (NFAT), nuclear factor-κB (NFκB) and cyclic-AMP responsive-element-binding 
(CREB) protein (Figure 2.4)





Figure 2.4: Calcium mediated intracellular signaling pathway in T cellsAs TCR–
pMHC–CD4/8 complex forms, Lck is recruited to phosphorylate ITAMs to allow 
docking of Zap70. This initiates phosphorylation of SLP76 and LAT, and activates ITK 
and PLCγ1. Together with PLCβ, PLCγ1 catalyse the hydrolysis of PtdIns(4,5)P2 to 
InsP3 and DAG. InsP3 binds to InsP3 receptors (InsP3Rs) for the release of ER stored 
Ca
2+
. STIM1 detects drop of Ca
2+
 in ER, then activates CRAC channels in the plasma 
membrane like Orai1 for Ca
2+
 influx.  These Ca
2+ 
activate calcineurin, and thereby some 





2.2 T cell recognition and the previous research 
2.2.1 TCR–pMHC interaction in T cell recognition 
 In molecular level, TCR–pMHC interaction is the key to T cell recognition. 
Although their affinity is about 100~1000 times lower than antibody-antigen interaction, 
they possess high sensitivity and specificity. TCR can sense few antigenic pMHCs out of 
a sea of self-pMHCs (10-100 out of 100,000 in MHC class I) and also able to respond to 
single amino acid difference in a short peptide sequence
27
. Unlike other surface adhesion 




2.2.2 T cell discrimination model 
 Several models have been proposed to describe T cell discrimination
27, 28
. Kinetic 
proofreading proposes that half life of TCR–pMHC binding determines ligand 
discrimination. However, there are outliers that have long half life but weak T cell 
response. TCR occupancy model proposes that number of TCR bound at a single time 
point is critical for ligand discrimination. However, in physiological condition we know 
that only few antigens are available and also previous study show that only a single 
ligand can activate T cell response. Serial triggering model suggests that number of TCR 
engagement over a period of time is the key for ligand discrimination. However, this 
model contradicts with the kinetic proofreading model where strong ligand with long half 
life cannot trigger many TCR. Thus, optimal dwell-time model proposes that there is 
optimal dwell-time that could enable serial triggering for strong ligands. However, this 
model is only tested in a mutant TCR system. Lastly, confinement time model combines 
on- and off-rate suggesting rapid rebinding is the key for ligand discrimination. However, 
these models are all based on non-physiologic measurements or mathematical 
calculations that have no supportive data. This is because T cell is a highly sophisticated 
system that cannot be explained from one aspect of observation or a conclusion. Also 
there are limitations of current state of experiment methods or tools that restrict the full 




2.2.3 Limitations of 3D measurements in TCR–pMHC interaction 
 TCR–pMHC interaction has intrigued many because of its low affinity (Kd ~1-
100μM) but high specificity and sensitivity
29-31
. Among many attempts to characterize 
the TCR–pMHC interaction, the most widely used method is using surface plasmon 
resonance (SPR) technique with soluble molecules in flow-governing conditions which 





analyses show the dissociation kinetics (“off-rate”) are the best predictor for the T cell 
response, with the agonist pMHC having a slower off-rate than the antagonist
32
. However, 
these analyses over simplifies the TCR-pMHC interaction. In microenvironment, not only 
TCR and pMHC but other components contribute in TCR–pMHC interaction such as co-
receptor binding to MHC and CD3 complex associates with TCR. Also, these molecules 
are constraint on 2-dimensional (2D) cellular membrane restricting the molecular 
movement only in lateral direction. In addition, how proximal signaling molecules are 
segregated to break the balance of activation and inhibition signaling and how TCR-
pMHC interaction transports the information through the membrane to the cytoplasmic 
tail are important considering factors in studying TCR–pMHC interaction. Lastly, 
extracellular/environmental contributions like cell migration or retrograde actin flow can 
apply physical force to TCR–pMHC interaction
37
. In fact, now TCR is thought as a 
mechanosensor since it can be triggered by mechanical force
38
. Therefore, there is a new 
need for understanding TCR-pMHC interaction with considering these contributions. 
 
2.2.4 2D measurements of TCR–pMHC interaction 
 Up to now, two techniques has been used to measure the 2D kinetics of the TCR–
pMHC interaction: one based on single-molecule Förster resonance energy transfer 
(FRET) by Mark Davis’ group
39
, and the other based on the membrane stretch of a red 
blood cell (RBC) in a micropipette adhesion frequency assay by Cheng Zhu’s group
1, 40-
43
. Huppa et al.
39
 studied FRET between lipid bilayer-anchored pMHC and TCR on CD4
+
 
T cells. The FRET readout between the fluorophore-labeled pMHC (MCC:I-E
k
) and 
5c.c7 TCR allowed the calculation of binding parameters. Their results showed that 2D 
binding kinetics were faster than their 3D counterparts and that 2D kinetics did not 
change with blockade of the CD4 co-receptor. Similarly using the micropipette adhesion 
frequency assay, Huang and our group
1
 found that 2D TCR binding kinetics were faster 
 
 13 
than their 3D counterparts and correlated well with T cell activation levels to altered 
peptide ligands in the CD8
+
 OT-I system (Figure 2.5). Not only did the 2D kinetics 
correlate well, but they also had a much larger dynamic range than the 3D kinetics.  
 
Figure 2.5: Comparison of 2D and 3D kineticsAffinities (A, D), on-rates (B, E), and 
off-rates (C, F) of the OT-I TCR interacting with indicated pMHCs are measured with 
adhesion frequency assay and compared with that of the 3D data (D-F) measured with 
SPR (adapted from  Huang et al., Nature, 2010)
1
.   
 
 Furthermore, CD8 affinity
40
 and its cooperativity
41
 was measured using 
micropipette adhesion frequency assay. These studies reported the basal affinity of CD8 
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co-receptor binding to MHC class I H-2K
b













, and cooperative binding of CD8 after approximately one-second of 
delay on TCR–pMHC interaction (Figure 2.7)
41
. In essence, CD8 form a trimeric 
interaction with TCR–pMHC resulting in an abrupt increase in binding. In comparison, 
there is currently no comparable analysis for the CD4 co-receptor. 
 
Figure 2.6: Adhesion frequency of CD8 binding to H-2K
b
Different level of adhesion 
frequency of CD8 binding to H-2K
b
 is measured with altering the density of MHC 





Figure 2.7: Two-stage kinetics of TCR–pMHC–CD8 trimolecular interaction 
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Adhesion frequency data of OT-I (A) and F5 (B) system show synergistic increase of 
adhesion frequency after one-second delay. These characteristics are CD8 dependent 
since anti-CD8 antibody or using MHC mutant eliminate the synergy (adapted from Jiang 




2.3 Thymic selection and the previous research 
2.3.1 Thymic selection 
 Thymocytes undergo multiple stages in thymic development to select-out fully 
equipped mature T cells for T cell immunity and central tolerance. One of the key check-
points in the thymic development is the positive and negative selection
44, 45
 (Figure 
2.8A). As the thymocytes engage with self-pMHCs on the cortical (cTEC) and medulla 
thymic epithelial cells (mTEc), they decide whether to live or die based on the binding 
propensity (avidity or affinity) to the self-ligand. First, thymocytes that do not have 
enough specificity to self antigen undergo apoptosis process. This is called “death by 
neglect
46
.” The ones with the “over-the-threshold” binding propensity will be deleted 
from the repertoire (thymocyte apoptosis, lineage deviation, and receptor editing) as 
“negative selection or clonal deletion.” Negative selection offers a key mechanism for 
self-tolerance since it removes the self-reactive T cells from the immune system that 
could potentially cause autoimmune disease in periphery
6, 7
. Thus, only the thymoyctes 
that have TCRs with optimal binding propensity to self-ligands will be positively selected. 
This process is called “positive selection
47
.” In addition to mentioned conventional 











, Natural Killer T cells (NKT cells)
50
, and CD8αα intestinal 
intraepithelial lymphocytes (iIELs)
51
 can occur from “agonist selection,” where high 
affinity TCR can be replaced to low affinity TCR by receptor editing or functionally 
inactivated (anergy)
45
. However, we still lack the understanding of how the thymocytes 
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distinguish the ligand strength and how signaling is initiated to facilitate in a totally 
different cell behavior. 
 
2.3.2 Previous research on thymic selection 
2.3.2.1 Receptor-ligand kinetics 
 Since TCR–pMHC interaction is critical in initiating the engagement and further 
translating the signaling cascade, studies have been conducted to identify a clear selection 
threshold parameter. One attempt was to characterize the selection threshold in kinetic 
parameters. The basic assumption of this approach is that occupancy time of single TCR 
determines the selection. This model is called “affinity model” and is based on “kinetic 
proofreading” model. Hogquist et al.
47
 used fetal thymic organ culture (FTOC) and 
showed that some variant of antigenic peptides induce positive selection. Alam et al.
33
 
measured kinetics of these ligands using SPR and correlated to the thymic selection. The 
kinetics of positive and negative selecting peptide showed some difference but whether 
there is a naturally occurring kinetic threshold for selection was questionable. Using SPR, 
tetramer staining, and photoaffinity labeling, only minimal difference (at most 2~3 times 
difference) was observed between the positive and negative selection ligands
52-54
. 
Although the differences in kinetic parameters were small, the threshold for two CD8 
systems (T1 and S14) coincided to a constant of Kd = 6μM
53
 (Figure 2.8B).  For a CD4 
system (3.L2), all the negative selecting ligands had half-lives of 2s or greater
54
.  In 
addition to the affinity threshold that were identified in thymus, King et al.
55
 recently 
showed that the same affinity threshold plays a role in maintaining peripheral tolerance in 
an autoimmune model. All together, it seems like the TCR affinity threshold exist and 
affects the peripheral immunity, but the magnitude of difference in affinity or kinetic 
parameters are smaller than expected which still leave the question of how thymocytes 




Figure 2.8: Thymic selection depends on T-cell receptor affinity for self 
pMHCPeripheral T cells are generated through the selection of self‑restricted and self-
tolerant 
thymocytes in the thymus. T cells that have TCRs that do not bind self-pMHC complexes 
and therefore do not receive a survival signal die by neglect; those with low affinity TCR 
to self pMHC complexes induces survival and differentiation (positive selection); 
whereas those with high affinity TCR to self-pMHC complexes induces cell death by 
apoptosis (negative selection) (A). Whether a self antigen induces positive or negative 
selection is defined by an apparent affinity threshold (Kd ~6 μM)
53
 of TCR–pMHC 




2.3.2.2 TCR complex 
 Another attempt to characterize a selection threshold is identifying changes in 
TCR complex. Many groups have studied CD3 conformational change to relate to thymic 
selection but it was not sufficient for a discriminating factor. Although negative selecting 
ligands induced conformational change in CD3 that activated programmed cell death
56
, in 
another study both positive and negative ligands enabled the exposure of a cryptic 
polyproline sequence in CD3ε that suits as a binding site for SH3.1 domain of cytosolic 
adaptor protein Nck
57
. In addition to CD3, co-receptors have also been considered in 
thymic selection. From mutant mouse experiments, CD3δ and α-CPM were identified to 
be critical in positive selection
58
 and further studies showed that CD8 associates with 
 
 18 
TCR through CD3δ and α-CPM
59
. Therefore, we know that CD3 and co-receptor like 
CD8 is important in thymic selection but these studies do not yet give a concluding 
understanding of how they can decide selection process. 
 
2.3.2.3 Signaling 
 In addition to the receptor-ligand kinetics and the TCR complex change, 
thymocyte signaling has been studied for thymic selection. Many groups were successful 
to observe qualitative differences in signaling kinetics (Ca
2+





, Erk, and LAT had transient peak activation and 
gradual decay for negative selection, those had a gradual increase in signaling kinetics for 
positive selection
44
. Also, while Ras/MAPK signaling molecules localized on the T cell 
membrane for negative selection, signaling localization was in the cytoplasmic golgi for 
positive selection
52
. In other studies, Nck recruitment and MINK correlated well with 
negative selection
60
, voltage-gated sodium channel (VGSC) was essential for the positive 
selection
61
, and thymocyte expressed molecule involved in selection (Themis) show close 




2.4 Motivations for the research 
 Although 3D measurements, such as SPR or tetramer staining, have provided 
information to study TCR–pMHC interaction so far, the native cellular environment 
differs from the conditions under which those experiments are performed. Whereas the 
native TCR is restricted to lateral 2D movement in a plasma membrane, SPR uses 
surface-immobilized ligands to detect binding with soluble receptor molecules which 
have freedom of 3D movement. In addition, cellular components (e.g., co-receptors or 
other membrane proteins) or motions (e.g., migration, actin radial flow, membrane 
deflection) could actively restrict or promote TCR binding to pMHC in a force dependent 
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manner. Thus, examining 2D TCR–pMHC binding kinetics in the more physiological 
membrane environment may yield important insights to T cell biology
1, 39
. This study 
attempts to answer how TCR discriminate ligand potency and decide thymic selection in 
more physiological condition with considering co-receptor CD4 or CD8 contribution.  
 
2.5 Significance 
 The fundamental mechanism of T cell activation and thymic selection are the 
central question in T cell immunity. We know the TCR–pMHC interaction combined 
with co-receptor contribution initiates the T cell recognition. However, the fundamental 
understanding of TCR–pMHC interaction is still not fully understood. In an attempt to 
provide more physiological characterization of TCR–pMHC interaction, this study 
considers 2D kinetics and physical force regulation in TCR–pMHC interaction which has 
not been well characterized before. Overall, this research contributes with a novel finding 









CHAPTER 3  MATERIALS AND METHODS  
3.1 T cells and proteins 
3.1.1 T cells 
 We used transgenic 3.L2, OT-I, and 2C mouse housed at the Emory University 
Department of Animal Resources facility in an experiment that followed protocol 
approved by the Institutional Animal Care and Use Committee of Emory University. The 
transgenic 3.L2 mouse expressed I-E
k
 MHC-restricted 3.L2 TCR specific to murine 
hemoglobulin (Hb) epitope 64-76 and the transgenic OT-I mouse expressed H-2K
b
 
MHC-restricted OT-I TCR specific to the chicken ovalbumin (OVA) epitope 257–264. 
We purified the naïve T cells from a mouse spleen using a CD4
+
 T cell isolation kit 







 double positive (DP) thymocyte enrichment by the magnetic bead 
immunoaffinity cell sorting (MACS) according to the manufacturer’s instructions 
(Figure 3.1). CD53 is a cell surface glycoprotein in a tetraspanin family that is known to 
contribute to cell adhesion, migration, and signaling. Furthermore, CD53 is only 




) positive thymocytes. Since CD53 expression and 
positive selection strongly correlated, we selected CD53 as a purification marker
65
. In 
more detail, we incubated the cell suspension from the spleen and thymus with anti-CD4 
negative selection magnetic beads and with anti-CD53 negative selection magnetic beads, 
respectively. Then we ran the mixture through a magnetic column for elution. We washed 
and stored the cells in RPMI 1640 (Cellgro)  supplemented with 10% FBS (Cellgro), 
2mM L-glutamine (Cellgro), 0.01M HEPES buffer (Cellgro), 100μg/ml gentamicin 
(Cellgro), and 2×10
-5
M 2-β-mercaptoethanol (2-BM) (Sigma-Aldrich), the complete 







purification for DP 3.L2 thymocytesSince CD53 expression and 
positive selection strongly correlated, we selected CD53 as a purification marker. CD53
-
 




 For the ligands of this study, we received synthesized recombinant pMHC 
monomers from the National Institutes of Health Tetramer Core Facility at Emory 
University. For 3.L2, system, a murine hemoglobin (Hb)-derived APL sequence was 
tethered to a gene sequence of I-E
k
 (an MHC class II molecule), which generated a 
peptide bound to an MHC molecule after the plasmids were expressed in the clones
66
. 
The peptide sequences were murine Hb-derived peptides Hb64-76 (GKKVITAFNEGLK, 
Agonist), T72 (GKKVITAFTEGLK, Weak agonist), I72 (GKKVITAFIEGLK, 
Antagonist), and A72 (GKKVITAFAEGLK, Weak antagonist)
36
. In addition, moth 
cytochrome c (MCC) peptide 88-103 (ANERADLIAYLKQATK) bound to IE
k
 were 
prepared in the same way for irrelevant control. For OT-I system, a chicken ovalbumin 
(OVA)-derived APL sequence was tethered to a gene sequence of H-2K
b
 or a mutant H-
2K
b
 (replacing the α3 domain in mouse H-2K
b
 to the α3 domain of human HLA-A2). The 
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peptide sequences were chicken OVA-derived peptides OVA257-264 (SIINFEKL, Agonist 
and negative selecting ligand), Q4 (SIIQFEKL, weak agonist and negative selecting 
ligand), Q4R7 (SIIQFERL, weak agonist and negative selecting ligand), T4 (SIITFEKL, 
weak agonist and negative selecting ligand), Q4H7 (SIIQFEHL, weak agonist and 
positive selecting ligand), and Q7 (SIINFEQL, weak agonist and positive selecting 
ligand), G4 (SIIGFEKL, weak agonist/antagonist and positive selecting ligand), Cappl92-
99 (ISFKFDHL, endogenous positive selecting ligand), Catnb329-336 (RTYRYEKL, 
endogenous positive selecting ligand)
52, 67, 68
. In addition, vesicular stomatitis virus-
derived nucleoprotein VSV52 -59 (RGYVYQGL) bound to H-2K
b
 was prepared in the 
same way for irrelevant control.  For 2C system, SIYR (SIYRYYGL, super agonist and 
possible negative selecting ligand), dEV8 (EQYKFYSV, agonist and positive selecting 
ligand), EVSV (RGYVYQEL, weak agonist and possible positive selecting ligand), p2Ca 










. All of the pMHC monomers were engineered to have a biotin tag on 
the C-terminus.  
 
3.2 RBC preparation and site density measurement 
3.2.1 RBC preparation and pMHC Coating 
 To anchor the pMHC monomers on the cell surface, we used human RBCs 
isolated from the whole blood of healthy volunteers according to a protocol approved by 
the Institutional Review Board of the Georgia Institute of Technology
1, 40, 41
. In more 
detail, 5ml of whole blood was drawn into an EDTA containing tube, overlaid onto 10ml 
of Histopaque (Sigma-Aldrich) and centrifuged five times in a PBS wash and twice with 
experimental additive solution 45 (EAS45) at RT. The isolated RBCs were stored in 
EAS45 at 4°C for further use of up to two months.  
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 Coating the pMHC onto the RBCs was conducted in three steps. First, we 
biotinylated RBCs with Biotin-XNHS (Calbiochem) according to the manufacturer’s 
instruction. That is, we washed the prepared RBCs in PBS three times, incubated them in 
titrated Biotin-X-NHS at pH 7.2 for 30min at RT, and washed them in PBS with 1% BSA 
five times to remove the Biotin-X-NHS. In the second step, we coated the biotinylated 
RBCs with streptavidin molecules. We incubated the RBCs in 0.5mg/ml streptavidin 
(Pierce) for 30min at 4°C and washed them in EAS45 three times. In the third step, we 
covalently linked the synthesized pMHCs with a single biotin on the C-terminus to the 
RBCs by the biotin-streptavidin interaction. 
 
3.2.2 Site density measurement 
 Since the site density of the receptor and the ligand are crucial for calculating the 
2D kinetics in the adhesion frequency assay, we measured their expression levels using 
flow cytometry analysis
1, 40, 41
 and obtained the expression level using PE-conjugated 
antibodies: anti-mouse Vβ8.3 TCR antibody (1B3.3, BD Pharmingen), anti-mouse Vα2 
TCR antibody (B20.1, BD Pharmingen), anti-mouse Vβ TCR antibody (F23.1, BD 
Pharmingen), anti-mouse CD4 antibody (GK1.5, eBioscience; RM-45, eBioscience), 
anti-mouse CD8 antibody (53-6.7, BD Pharmingen), anti-mouse H2-I-E
k
 monoclonal 
antibody (17-3-3, Santa Cruz ; 14-4-4s, BD Pharmingen), anti-mouse OVA257-264 
(SIINFEKL) peptide bound H-2K
b 
monoclonal antibody (25-D1.16, eBioscience), anti-
mouse H-2K
b 
monoclonal antibody (AF6-88.5, BD Pharmingen), and β-2-microglobulin 
antibody (S19.8, Santa Cruz Biotechnology). For isotype control, PE-conjugated 
antibodies were used: rat IgG2a κ (eBioscience), mouse IgG2a (Santa Cruz 
Biotechnology), and hamster IgG3 λ1 (BD Pharmingen). We incubated the antibodies at 
10μg/ml concentration in 100μl of FACS buffer (PBS without calcium and magnesium, 
5mM EDTA, 1% BSA, 25mM HEPES, 0.02% sodium azide) at 4°C for 30min; measured 
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the fluorescent intensity by the BD LSR II flow cytometer (BD Biosciences) (Figure 
3.2); and calibrated the site density according to the BD QuantiBRITE PE standard beads 
(BD Biosciences). 
 
Figure 3.2: TCR expression level of OT-I naïve T cells and thymocytesAn example of 
flowcytometry PE histogram using anti-mouse Vβ8.3 TCR antibody on OT-I naïve T 
cells and thymocytes. Site density of the receptor and the ligand were measured using 
specific antibodies with flowcytometry analysis. Fluorescent intensity from 
flowcytometry histogram was calibrated to site density using PE standard beads.  
 
3.3 2D mechanical assays  
3.3.1 Micropipette apparatus  
 We customized an inverted microscope (TMD Diaphot, Nikon) by mounting two 
identical sets of 3D mechanical manipulators (Newport) on each side of the microscope 
stage to hold apposing glass pipettes for capturing the cells (Figure 3.3). Because the 
pipettes were linked to a home-made manometer system, the applied suction pressure 
held the cells and controlled the contact of a pMHC presenting an RBC onto a T cell. A 
one-dimensional (1D) open-loop piezo actuator LVPZT (P840-1, Physik Instrumente) 
mounted on one side of the pipette allowed repeated approach and retract movements 
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controlled by voltage generation from LabVIEW software (National Instruments) and 
DAQ 6008 (National Instruments). Using an analog CCD camera (MTI DC330, Dage), 
we acquired real-time images at 30 frames per second and simultaneously observed them 
through a TV monitor and recorded them on a VHS cassette tape.  
 
 
Figure 3.3: Micropipette setupAn inverted microscope (TMD Diaphot, Nikon) was 
customized to have two sets of 3D mechanical manipulators (Newport) on each side of 
the stage with a home-made manometer system connection to hold apposing glass 
pipettes for capturing the cells.  
 
3.3.2 Adhesion frequency assay 
 Using the micropipette adhesion frequency assay
73
, we measured the 2D kinetics 
of the TCR-pMHC interaction. Two micropipettes held a single purified T cell on one 
side (glass pipette with a ~2μm inner diameter) and a single pMHC-coated RBC on the 
other (a glass pipette with a ~1μm inner diameter) (Figure 3.4A) in a chamber filled with 
an L-15 medium (Sigma-Aldrich) plus 5mM HEPES and 1% BSA. While a controlled 
piezoactuator linked to the pipette on the RBC side generated a repeat approach-retract 
 
 26 
cycle, we observed binary events of adhesion (either 1, which represents the binding 
event shown in Figure 3.4B, or 0, which represents the no-binding event shown Figure 
3.4C) by the deflection of the RBC membrane.  
 
Figure 3.4: Micropipette adhesion frequency assay and thermal fluctuation assay 
A single native T cell/thymocyte and a pMHC-coated RBC are held by two apposing 
micropipettes before the contact (A). The TCR, CD4, CD3 and the other native forms of 
molecules are presented on the native T cell/thymocyte surface. On the RBC surface, the 
biotinylated pMHC is linked to streptavidin to covalently bind to the 2D surfaces. For the 
adhesion frequency assay, we bring apposing cells to a contact for certain contact 
duration and retract to observe the adhesion frequency. Since binding events are binary, 
we can either observe a binding event from the elongation of the soft membrane of RBC 
(B) or no binding from no stretch events (C).  
 
 We repeated this approach-contact-retraction cycle 50 times for three to five cell 
pairs at each single contact duration (tc) with a consistent contact area (Ac), resulting in a 
calculation of an adhesion frequency (Pa , mean ± SEM). Then we measured the site 
densities of the TCR (mr) and the pMHC (ml) from a flow cytometry analysis, derived the 
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results of Pa at different contact durations (0.1s-5s), and curve fitted the adhesion 




)}]exp(1{exp[1 coffaclra tkKAmmP  .    (1)
 
We fit each binding curve using nonlinear regression to this probabilistic kinetic model 
for a single-step monovalent receptor ligand interaction. Since mr, ml, and Pa can be 
measured with varying tc’s with controlled Ac, the equation consisted of two unknown 
parameters, AcKa and koff.  We derived these parameters from the curve fit using the least 
mean square method (Excel Solver) and evaluated the data from repeated experiments 
(n≥3) with different TCR and pMHC densities. 
 To measure the non-specific adhesion, we conducted controlled experiments at a 
5s contact duration for both 3.L2 naïve T cells and OT-I thymocytes. For 3.L2 naïve T 
cells we tested binding to (1) unmodified RBCs, (2) biotinylated RBCs, (3) biotinylated 
RBCs linked to streptavidin, (4) biotinylated RBCs linked to streptavidin and coated with 
irrelevant pMHC-I (OVA257-264:H-2K
b
), (5) biotinylated RBCs linked to sreptavidin and 
coated with irrelevant pMHC-II (MCC88-103:IE
k
), and (6) biotinylated RBCs linked to 
streptavidin and coated with antigenic Hb64-76:IE
k
 (Figure 3.5A). Observed binding 
frequencies were less than 1% for unmodified RBCs, biotinylated RBCs (800μM 
biotinylated concentration), and biotinylated RBCs linked with streptavidin (4335 
molecules/μm
2









). However, the observed frequency was 
~75% for the specific antigen Hb64-76:IE
k








 For OT-I thymocytes we tested binding to (1) unmodified RBCs, (2) biotinylated 
RBCs, (3) biotinylated RBCs linked to streptavidin, (4) biotinylated RBCs linked to 
streptavidin and coated with irrelevant peptide-mutant MHC-I (VSV:mH-2K
b
), (5) 





), and (6) biotinylated RBCs linked to streptavidin and coated with 
antigenic peptide-wild type MHC-I (OVA257-264:H-2K
b
) (Figure 3.5B). Observed 
adhesion frequencies were less than 1% for unmodified RBCs, biotinylated RBCs 
(800μM biotinylated concentration), and biotinylated RBCs linked with streptavidin 
(4335 molecules/μm
2









 at the similar 




 = ~13 molecules/μm
2
) 
were  ~15% and  ~53%, respectively. 
Figure 3.5: Non-specific adhesion control experiment 
To measure the non-specific adhesion, we conducted controlled experiments at a 5s 
contact duration for 3.L2 naïve T cells and OT-I thymocytes. For 3.L2 naïve T cells, 
specific adhesion was tested with the unmodified RBCs, the biotinylated RBCs, the 
biotinylated RBCs linked with streptavidin, the biotinylated RBCs linked with 
streptavidin coated with irrelevant pMHC-I (OVA:H-2K
b
), irrelevant pMHC-II (MCC:I-
E
k
), and antigenic Hb64-76:I-E
k
 (A). For OT-I thymocytes, specific adhesion was tested 
with the unmodified RBCs, the biotinylated RBCs, the biotinylated RBCs linked with 
streptavidin, the biotinylated RBCs linked with streptavidin coated with irrelevant 
peptide-mutant MHC-I (VSV:mH-2K
b
), antigenic peptide-mutant MHC-I (OVA257-
264:mH-2K
b
), and antigenic peptide-wild type MHC-I (OVA257-264:H-2K
b
) (B). Each bar 
is presented as mean ± SEM (n≥5).   
 
3.3.3 Thermal fluctuation assay 
 Using biomembrane force probe (BFP), we measured koff by performing thermal 
fluctuation assay
74
. Because of BFP’s high resolution and soft spring constant, thermal 
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fluctuation assay gave better measurement of koff than adhesion frequency assay. BFP 
used RBC as a displacement sensor to detect TCR-pMHC bond formation using a high-
speed CCD camera (Figure 3.6A). A RBC was held by a micropipette with controlled 
suction pressure to allow the RBC to have a spring constant of kp = 0.15pN/nm
1, 74
. 
pMHCs were coated on a borosilicate bead (2-mm diameter, Duke Scientific) and 
attached to the apex of a RBC held on a micropipette. A native T cell held by an apposing 
micropipette was positioned to approach the bead with a certain distance to allow TCR-
pMHC bond formation due to thermal fluctuation. A high-speed CCD camera (1,500 
frames/s, Graftek Imaging) captured a well-defined greyscale profile of the edge of the 
bead to track the axial position of the bead with a 5nm spatial and 0.7ms temporal 
resolution. The bond formation and dissociation was detected by the reduction and 
resumption of the thermal fluctuations of the BFP bead
1, 74
. We were able to detect these 
bond lifetimes (tb), i.e., from the instant of bond association to the instant of bond 
dissociation, by analyzing the displacement and the standard deviation of the bead 
movement (Figure 3.6B).  
 
Figure 3.6: Thermal fluctuation assay 
A single native T cell/thymocyte and a pMHC-coated bead are held by two apposing 
micropipettes before the contact (A). The TCR, CD4, CD3 and the other native forms of 
molecules are presented on the native T cell/thymocyte surface. On the bead surface, the 
biotinylated pMHC is linked to streptavidin to covalently bind to the 2D surfaces. For the 
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thermal fluctuation assay, we bring apposing cell and the bead to a certain distance to 
allow bond formation that gives reduction in the standard deviation of the bead 
movement (B).  
 
 Modeling the kinetic process as a single-step first order dissociation of a single 
monomeric TCR-pMHC bond, the probability Pb of a bond formed at time 0 to remain 
intact at time tb is 
)exp( boffb tkP  .                                                               (2)
 
We can take a natural log to the linearized exponential function on right hand-side of this 
equation to plot the bond lifetime data as ln(number of events with a lifetime > tb) versus 
tb. We can then estimate koff from the negative slope of the line (Figure 3.7). 
 
Figure 3.7: Bond lifetime distribution from thermal fluctuation assay in 3.L2 system 
Using single-step first order dissociation model, the bond lifetime data was linearlized to 
plot ln(number of events with a lifetime > tb) versus tb to estimate koff from the negative 
slope of the line. 
  
3.3.4 Force-clamp assay 
 We measured force-dependent bond dissociation with using same BFP apparatus 
but with clamped-force applied to the TCR–pMHC bond
75-77
. The pipette holding the T 
cell was driven repeatedly to approach and make a contact with the bead at a 15pN 
compressive force for 0.2s for TCR-pMHC bond formation. After this brief contact, the 
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pipette was retracted at a 3μm/s speed (RBC spring constant of kp = 0.3pN/nm, retraction 
speed 1000pN/s) to be held at a desired force (i.e., clamped-force) to wait for bond 
dissociation. At this point the adhesion was detected by a tensile force signal caused by 
RBC membrane deformation (i.e., displacement of the BFP beads). Lifetime was 
measured from the instant when the force reached the desired level to the instant of bond 
dissociation (Figure 3.8A). To avoid force drift over long time, a 10s cutoff was set to 
rupture bonds with lifetimes larger than 10s. After the bond dissociation, the program 
returned T cell held pipette to the original position for the next cycle. We repeated this 
cycle to obtain more than 300 lifetime events at a force range of 5-40pN for each TCR–
pMHC interaction. We used 5-7 bins to segregate the force-lifetime data for presentation. 
In order to affirm the condition for monomeric interaction of more than 95%, the pMHC 




Figure 3.8: Force-clamp assay and stiffness analysis 
The T cell was driven repeatedly to impinge, make a contact with the bead, then retract to 
be held at a desired force to wait for bond dissociation (A, C). Adhesion was detected by 
a tensile force signal caused by RBC membrane deformation and bond lifetime was 
measured from the instant when the force reached the desired level to the instant of bond 
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dissociation (A). In addition, the ramping phase of BFP cycles (shaded in A) can be 
zoom-in for force vs. extension curve (B). The slopes from this curve represent serially 
connected components: cells (slope1) and cell plus the molecular interaction (slope2). 
From linear curve fitting kcell and kbond are derived. 
 
3.3.5 Stiffness analysis 
 We measured the stiffness of molecular bonds from the ramping phase of BFP 
test cycles
75, 78
. The ramping phase of BFP cycles (colored in Figure 3.8A) can be zoom-
in to read force vs. extension curve (Figure 3.8B). The extension is the differential 
displacement between the BFP tracking system and the piezoelectric actuator feedback 
system. Therefore, the slope of this curve is the stiffness of serially connected 
components: cells (RBC and T cell) and the molecular interaction (TCR–pMHC) (Figure 
3.8C). Two slopes appeared in the ramping phases: one (slope1) from compressive force 
and the other with decreased slope (slope2) from tensile force (Figure 3.8B). Since the 
slope under compression was higher, we assumed the molecular complex can resist 
tension but not compression, and the cellular spring has the same value regardless of 
whether the cell surface is in tension or compression. We verified this assumption with 
using purified molecules coated beads to measure kmol and calculate tension kcell from 
slope2. Our data indicate that tension kcell and compression kcell are not significantly 
different (Figure 3.9). Therefore, with linear curve fitting of the data, we estimated kcell 
from the slope1 (slope1 = kcell) and calculated kbond from slope2 (slope2 = 1/(1/ kcell + 




Figure 3.9: Cellular stiffness comparison 
From purified molecules coated beads experiment, we measured kmol to calculate tensile 
kcell from slope2 of force vs. extension curve and compared to the compressive kcell from 
slope1. No significant difference was observed (p=0.3). Bars are presented as mean ± 
SEM (n≥140) 
 
3.4 3D Surface plasmon resonance  
 3D TCR–pMHC binding kinetics were analyzed using a Biacore 2000 surface 
plasmon resonance instrument
79
 from Paul Allen’s lab in Washington University in St. 
Louis. CM5 sensor chips (GE Healthcare) were activated with a 20minute pulse with a 
1:1 mixture of 100mM N-hydroxysuccinimide (NHS) and 75mg/mL 1-ethyl-3-[3-
dimethylaminopropyl] carbodiimide hydrochloride (EDC). NeutrAvidin (Pierce) was 
immobilized to the chip via amine coupling using a solution of ~100g/mL NeutrAvidin 
in 20mM sodium citrate buffer pH 4.5. Unreacted NHS groups on the chip surface were 
blocked with a 6-minute pulse of 1M ethanolamine pH 8.5. Biotinylated pMHC monomer 
was then coupled to the chip to a total response level of ~1000 resonance units (RU). For 
binding analysis, concentration series of scTCR covering at least two orders of magnitude 
were injected in duplicate at 25°C over surfaces coupled with monomeric peptide:I-E
k
, 
using a flow rate of 30μL/min. Running buffer for all experiments was HEPES-buffered 
saline (10mM HEPES, 3mM EDTA, 150mM NaCl and 0.005% Tween-20). All 
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sensorgrams were corrected for nonspecific binding by subtracting the response from a 
surface coupled with CLIP:I-E
k
, and corrected for bulk flow effects by subtracting the 
response obtained from plain buffer injection. 
 Sensorgrams from scTCR concentration series injections were fitted to a 1:1 
Langmuir binding model using BiaEvaluation version 4.1 to derive the 3D koff, kon, and 
Ka (=1/Kd=kon/koff).  Kd and maximum response (RMax) values for equilibrium binding 
analysis were obtained by plotting the equilibrium response (Req) at each concentration 
and fitting these data to a one-step binding model using GraphPad Prism version 6.0a for 
Macintosh (GraphPad Software, San Diego, CA). Scatchard plots were generated to 
confirm 1:1 binding stoichiometry by graphing Req/[TCR] versus Req. 
 
3.5 Concurrent calcium imaging 
 In addition to the micropipette setup, we added fluorescent imaging capabilities to 
allow concurrent micromanipulation and calcium imaging (Figure 3.10). Two light 
sources were used to get bright field image (halogen lamp) and fluorescent image (xenon 
lamp). Since Fura2 required radiometric analysis, dual excitation filters (340 and 380 nm) 
were switched automatically using a filter wheel (Lambda LS, Sutter) and a controller 
(Lambda 10-3 controller, Sutter). With using dual channel imaging system (DC-2, 
Photometrics), the bright field wavelength filtered with 610nm red filter and the emission 
wavelength from Fura2 were separated to its respective cameras. A dichroic mirror with 
565nm long-pass filter was used. A digital digital camera (CoolSNAP HQ2, 
Photometrics) and the NIS-Element software (Nikon) was implemented for fluorescent 
image acquisition and image analysis. 
 For loading the calcium indicator, T cells were loaded with 4μM Fura-2/AM, 
incubated for 30min at 37°C, washed twice with Ca
2+
 free PBS buffer (pH 7.4). Then, T 
cells and RBCs pre-coated with pMHC were transferred into L-15/HEPES media 
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(SIGMA) containing microscopic chamber. For simultaneous adhesion frequency assay 
and calcium imaging, each T cell and RBC pair was tested repeatedly for total 10 min of 






Figure 3.10: Concurrent micromanipulation and calcium imaging system An 
inverted microscope (TMD Diaphot, Nikon) was customized by mounting two sets of 
mechanical manipulators on the two sides of the stage. A piezo actuator is mounted on 
one side to drive micromanipulation of glass pipette for adhesion frequency assay. 
Concurrent detection of adhesion frequency and calcium signaling is enable by splitting 
the bright field light and Fura-2 excitation wave lengths. Decoupling the bright field and 
fluorescent images is obtained by using 610-nm long-pass filter for bright field light and 
DC2 system with 565 nm long-pass dichroic mirror for fluorescent imaging. 
 
3.6 Blocking reagents 
 Prior to the CD4 blocking experiment, we used a purified anti-mouse CD4 
monoclonal antibody (GK1.5, eBioscience) to incubate the T cells and injected them into 
the experiment chamber at the same concentration
39, 80
. That is, we incubated the purified 
3.L2 T cells with the CD4 blocking antibody at 20μg/ml in 100μl for 30min in 4°C and 
then tested them in the experiment chamber with the presence of 20μg/ml antibodies. For 
the 3.L2 TCR blocking experiment, we used an anti-3.L2 clonotypic antibody (CAb) 
donated by Dr. Brian Evavold at Emory University. We incubated the purified T cells at 
50μg/ml in 100μl for 30min in 4°C, and then tested them in the experiment chamber in 
the presence of 50μg/ml CAb. 
 For the blocking of OT-I TCR and CD8, we incubated DP thymocytes with 
purified anti-mouse TCR Vα2 monoclonal antibody (B20.1, eBioscience) and CD8 
monoclonal antibody (CT-CD8a, LifeSpan Biosciences), respectively, prior to the 
experiment and injected the antibodies into the experiment chamber to maintain the same 
antibody concentration
41
. That is, we incubated the purified DP thymocytes with 
antibodies at 50μg/ml in 100μl for 30min in 4°C and then tested them in the experiment 
chamber in the presence of antibodies with the same concentration.   
 For the inhibition of Lck, we used a Src tyrosine kinase inhibitor PP2 (4-Amino-
5-(4-chlorophenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine) from Biomol (Plymouth 
Meeting, PA).  We preincubated DP thymocytes with 10mM PP2 for 10min at 25°C and 
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tested them during the next 10min with a continuous presence of PP2. Since PP2 is 
effective in only a 10-min window, we replaced the sample every 10min.  
 To disrupt microfilament organization, we used latrunculin A (Calbiochem). 
latrunculin A bind to monomeric G-actin to inhibit actin filament organization. We 
preincubated DP thymocytes in 1μM for 30min at 25°C and then tested them in the 
experiment chamber in the presence of latrunculin A with the same concentration.   
 
3.7 Statistical analysis 
 We statistically compared data using the Student’s t-test or one-way ANOVA. 
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CHAPTER 4  IN SITU 2D KINETICS AND FORCE 
REGULATION OF 
TCR–pMHC INTERACTION IN CD4
+
 T CELL FUNTION 
4.1 Introduction 
 Previous study with using adhesion frequency assay showed CD8 cooperates to 
TCR–pMHC interaction in signaling dependent manner
41
. Also, recent reports suggested 
2D kinetic results have wider dynamic range to predict the T cell response with faster on-
and off-rate than the previous reported 3D kinetics
1, 39
. In addition, recent study shows 
that force regulates bond lifetime in TCR–pMHC interaction for T cell activation (Liu et 
al. Cell in press). Indeed TCR–pMHC interaction is exposed to a physical environment 
including cellular components (e.g., co-receptors or other membrane proteins) or cellular 
motions (e.g., migration, actin radial flow, membrane deflection) that could actively 
restrict or promote TCR binding to pMHC in a force dependent manner. Therefore, force 
regulation could be critical in TCR–pMHC interaction. In this chapter, we expanded the 
analysis of 2D TCR binding kinetics and contribution of force regulation to a class II-
restricted T cell model. We anticipated testing the hypothesis of “in situ 2D kinetics and 
force regulation of TCR–pMHC interaction better define T cell response than previous 
3D methods in MHC class II system.” Three specific aims are tested: 1) Quantify 2D 
kinetic parameters of 3.L2 TCR to analogues of Hb68-76 ligand bound MHC II in naïve 
T cell to better predict the T cell response; 2) Compare 2D and 3D measurements to 
confirm the differences and the advantage of 2D kinetic parameters; 3) Analyze force 
regulation in TCR–pMHC interaction for T cell response. 
 To derive the in situ 2D kinetics, we used native T-cells purified from the 3.L2 
TCR transgenic mouse system, and red blood cells (RBCs) covalently coated with 
purified cognate pMHC (Hb64-76:I-E
k
) or altered peptide ligands (APLs) in the 
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micropipette apparatus. The effective 2D affinity and the effective 2D on-rate positively 
correlated with the functional T cell response whereas the 2D off-rate showed negative 
correlation. Compared to previous 3D parameters, 2D parameters better correlated to a 
series of related pMHCs for this system. When force was applied to these TCR–pMHC 
interactions, agonist and weak agonist showed catch-slip bond and antagonists showed 
slip bonds. These findings indicate force regulation can contribute to ligand 
discrimination. Lastly, the results revealed that CD4 has a substantially lower affinity to 
MHC class II and did not cooperate to TCR binding under zero-force. However, under 
force-regulation CD4 contributes significantly to bond lifetime for the agonist ligand.  
 
4.2 Results 
4.2.1 Affinity of CD4 to I-Ek  
 Before analyzing the characteristics of TCR–pMHC interaction in 2D kinetics, we 
first wanted to verify the lack of CD4 contribution to TCR–pMHC binding. Although, 
CD4 has been previously shown to not contribute to TCR–pMHC binding by FRET 
experiments
39
 and computational modeling
81
, we conducted the adhesion frequency assay 
that have better sensitivity for verification. We tested the effect of blocking TCR and 
CD4 by pre-incubating T cells with the anti-3.L2 clonotypic antibody (CAb) and the CD4 
blocking antibody (GK1.5) and then performed the adhesion frequency assay on naïve 
CD4
+
 T cells against Hb64-76:I-E
k
-coated RBCs with the presence of the antibody in the 
experiment chamber. Adhesion frequency data showed that CAb treatment reduced the 
binding frequency but GK1.5 treatment did not (Figure 4.1A) indicating that TCR–





Figure 4.1: Contribution of CD4 in adhesion frequencyThe TCR blocking antibody 
(CAb) and the CD4 blocking antibody (GK1.5) were used to incubate the cells prior to 
the experiment, which was conducted in the presence of the antibody for the blocking 
treatment. The CAb treatment resulted in a drop in the binding frequency but the GK1.5 
treatment did not affect the binding curve (A). In addition, the irrelevant peptide MCC88-
103:I-Ek was coated on the RBCs to test the binding frequency between the CD4 and I-Ek. 
Some binding was observed at the longer contact duration (5s) with a high site density 
over 4,000 molecules/μm2, but overall the binding was very low (<10%) (B). Because of 
the low binding frequency, blocking CD4 with GK1.5 did not produce a significant 





): Hb64-76 (116:34),  Hb64-76 + GK1.5 (116:34), Hb64-76 + CAb 
(163:28), MCC (136:4483, 315 for CD4), and MCC + GK1.5 (136:4483, 315 for CD4). 
Each binding frequency measurement is presented as mean ± SEM (n≥3) from 50 touches 
each. The data are representative from at least two independent experiments.   
 
 In order to directly measure CD4 binding, we tested the binding frequency of the 
irrelevant MCC88-103:I-E
k
 to CD4 (Figure 4.1B). We did observe binding at a longer 
contact duration (5s) with the highest possible site density on a RBC over 4,000 
molecules/μm
2
, but overall the binding was very low. The low binding between CD4 and 
MHC class II (I-E
k




 in 2D effective affinity. These 
results coincide with those of previous research confirming that CD4 does not enhance 
TCR binding
39, 42, 82
. Thus, we confirmed the lack of CD4 contribution supporting a 
dimeric interaction between the TCR and the pMHC. Here after, all of the measurements 
were derived using bimolecular interaction kinetic models, assuming that the adhesion 
frequencies and bond lifetimes were mediated by TCR–pMHC interactions with no CD4 






4.2.2 Zero-force kinetic analysis of 3.L2 TCR–pMHC interaction 
 To compare with our previous zero-force analysis of the MHC class I-restricted 
TCR systems, we analyzed the 2D binding affinities and kinetic rates of the 3.L2 TCR 
(MHC class II-restricted). A series of well-characterized ligands were tested, including 
the wild-type peptide Hb64-76 and three APLs with a single amino acid alteration at 




. To reliably 
evaluate the distinct 2D affinities of Hb64-76 (agonist), T72 (weak agonist), I72 
(antagonist), and A72 (weak antagonist), different pMHC densities were coated on the 
RBCs in order to obtain mid-ranged adhesion frequencies for all ligands (Figure 4.2A). 
We were then able to define 2D binding kinetics for all of the ligands (Figure 4.2, Table 
1), including the weak antagonist A72 with lowest potency that was not previously 
detectable using SPR
36
.   
 
Figure 4.2: 2D kinetic measurements and the comparison between 2D vs. 3D 
kineticsThe adhesion frequency assay was conducted through a different panel of 
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peptides (Hb64-76, T72, I72, A72, and MCC (an irrelevant peptide)) (A). The measured 2D 
kinetics are compared to the 3D SPR data (B, C, D). Each 2D kinetic measurement is 
presented as mean ± SEM (n≥3). The data in (A) are representative from at least three 
independent experiments. 
  
 The 2D affinity was derived from the adhesion frequency curve-fitting data with a 
probabilistic kinetic equation that accounts for the different ligand densities (see 
Materials and Methods) (Figure 4.2B)
73
. The effective 2D affinity, AcKa, occurred over a 




) with the agonist Hb64-76 displaying the highest affinity 
and the weakest antagonist A72 ligand the lowest affinity. In addition to the 2D off-rates 
derived from the adhesion frequency assay, the thermal fluctuation assay was also used, 
to obtain more accurate off-rate values from analysis of single-bond lifetime 
measurements
74, 84
 (Figure 4.2D). These thermal fluctuation data show 2D off-rates, koff, 
which also accurately reflected ligand potency ranging from the Hb64-76 to A72 with a 
range (1.22-3.79 s
-1
). The effective 2D on-rate, Ackon, was calculated by multiplying the 







) that reflected ligand potency. When comparing to OT-I system, the values 
of effective 2D affinity and on-rate for the tested ligands in 3.L2 system fall in the range 
of A2 (agonist) and G4 (weak agonist)
1
. However, 2D off-rate in 3.L2 system showed 
negative correlation to the ligand potency which was in opposite to that of the OT-I 
system
1








4.2.3 Comparison of 2D and 3D kinetic parameters 
 Previously, Kersh et al.
36
 reported SPR measurements for the tested panel of 
peptides using double-chain TCR. However, in order to directly compare with our 2D 
parameters, our collaborator Paul Allen’s lab measured new 3D kinetic parameters with 
SPR method using single-chain TCR and peptides covalently linked I-E
k
 as in the 2D 
measurements (Table 2). Whereas Hb64-76 and T72 3D SPR measurements were readily 
calculated by simultaneous modeling of kon and koff, injection spikes coupled with 
extremely fast kinetics precluded successful curve fitting for I72 and A72. The 3D SPR 
measurements for these ligands were instead derived by separately modeling the kon and 





Table 2: 3D kinetics and binding affinities of 3.L2 TCR–pMHC interactions from 
SPR 
 
*3D kon and koff for I72 and A72 were derived by separate modeling using data from the 
sensorgram corresponding to the highest scTCR concentration injection. 
 
 Several differences were observed in comparison between the 2D and 3D kinetic 
parameters as shown in Figure 4.2B-D and Figure 4.3. First, the effective 2D affinity 
correlates with the peptide potency to activate T cell response
36, 83
, showing a higher 
affinity for the agonist peptide and a lower affinity for the antagonist peptide (Figure 
4.2B). Although the 2D and 3D affinities showed positive correlation (p<0.05), the high 
R
2
 value (0.9) may be due solely to their much higher values for the agonist pMHC than 
the other three APLs, which could be resolved by the 2D, but not 3D, analysis (Figure 
4.3A). For this reason, no correlation was observed between the 3D affinity and peptide 
potency (Figure 4.2B). 
In the case of on-rate, the ligand potency positively correlated to the effective 2D 
on-rate (Figure 4.2C). However, the 3D on-rate showed an opposite trend: a high on-rate 
for the low potency ligands and a low on-rate for the high potency ligands (Figure 4.2C). 
Therefore, 2D and 3D on-rates poorly correlated (R
2
=0.14, p>0.5) (Figure 4.3B). In the 
case of off-rates, the ligand potency negatively correlated to the 2D off-rate (Figure 
4.2D) and the 3D off-rate also showed similar trend (Figure 4.2D). Therefore, 2D and 3D 
off-rates showed significant correlation (R
2




Figure 4.3: Correlation between 2D and 3D kineticsThe effective 2D affinity shows a 
close correlation (R
2
=0.9, p<0.05) to the 3D affinity but only due to high magnitude of 
the agonist Hb (A). The effective 2D on-rate poorly correlates (R
2
=0.14, p>0.5) to the 3D 
measurements (B). Only the 2D off-rate showed a strong correlation (R
2
=0.87, p<0.1) 
with the 3D measurements (C). The mean values were used for comparison for both 2D 
and 3D kinetics. 
 
To further examine the functional correlation of the 2D kinetics of the 3.L2 TCR–
pMHC interaction, we plotted functional T cell response against the effective 2D affinity 
(Figure 4.4A), on-rate (Figure 4.4B) and off-rate (Figure 4.4C). Because T cells can 
induce ligand dependent induction of B cell apoptosis, the ligand concentration required 
to generate 40% B cell apoptosis (EC40) was chosen as a T cell response readout from the 
previous research
83
. Positive correlations were found for the effective 2D affinity 
(R
2
=0.84) and 2D on-rate (R
2
=0.36) (Figure 4.4A and B). With the 2D off-rate, negative 
correlations were observed (R
2
=0.92) (Figure 4.4C). However, the correlation was 
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compressed compared to that of OT-I system only showing a single-log of magnitude 2D 
kinetics correlating to six-log of magnitude T cell response. 
 
Figure 4.4: Correlation between 2D kinetics and T cell responseThe effective 2D 
affinity shows a close correlation (R
2
=0.84) to a reciprocal of the ligand concentration 
that required to produce 40% B cell apoptosis (EC40) (A).  The effective 2D on-rate also 
shows a positive correlation (R
2
=0.36) (B).  The 2D off-rate shows a negative correlation 
(R
2
=0.92) to 1/EC40 (C).  The parameters used for the 2D kinetics are the mean values 
from the adhesion frequency assay and thermal fluctuation assay. The EC40 values are 




4.2.4 Force-regulated dissociation kinetics of in situ 3.L2 TCR–pMHC interaction 
 In addition to the importance of TCR–pMHC interaction on a 2D membrane, 
several recent studies have proposed that the TCR recognize physical force to activate T-
cells
38, 85-88
. In order to dissect the physical force contribution in T cell recognition, we 
conducted force-clamp assay to measure force-dependent dissociation kinetics. The 
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experiments were conducted in two difference T cell populations from mouse splenocytes 

















) from 3.L2 
transgenic mouse splenocytes (Figure 4.5). When testing these two T cell populations in 
zero-force adhesion frequency assay, CD8
+
 3.L2 T cells showed a similar effective 2D 
affinity to CD4
+
 3.L2 T cells against APLs (Figure 4.6), further supporting CD4 does not 
contribute to TCR–pMHC interaction in zero-force condition.  
 








 3.L2 T 
cellsFlowcytometry analysis shows distinct two populations based on the CD4 and CD8 








 3.L2 T cells were purified with respective 









 3.L2 T 




 3.L2 T 
cells show similar level for APLs. Each bar is presented as mean ± SEM (n≥5).  
  
 However, the stiffness analysis from the force-clamp assay shows CD4 





 3.L2 T cells (Figure 4.7), we were able to fit the histogram 
with single Gaussian distribution except Hb in CD4
+
 3.L2 T cells (Figure 4.7A). For the 
stiffness histogram of CD4
+
 3.L2 T cells binding to Hb, two-Gaussian distribution fit 
better than a single Gaussian distribution indicating the possibility of two kind of bond 
formation. However, the stiffness histogram of CD8
+
 3.L2 T cells binding to Hb showed 
a single Gaussian fit. Together, it suggested CD4 could contribute in TCR–pMHC 
interaction under force. However, this phenomenon was not detectable with other weaker 
ligands (Figure 4.7C, D, E, F, G, and H).  
 Next, from force-clamp assay we plotted force vs. bond lifetime curve (Figure 
4.8). For agonist Hb, with or without CD4 condition showed catch-slip behavior where 
bond lifetime increases, reach a maximum then decrease to force. However, the 
magnitude of the peak bond lifetime was dependent on the presence of CD4. For CD4
+
 T 
cell (red circle, Figure 4.8A) the peak bond lifetime reached maximum of 3.2s at 10pN 
whereas the peak bond lifetime with CD4 blocking antibody (yellow triangle, Figure 
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4.8A) or CD8+ T cell (blue square, Figure 4.8A) reached only 2s at 12pN. Thos events 
that had bond stiffness larger than the second peak (0.53pN/nm) in the stiffness analysis 
(green diamond, Figure 4.8A) indeed showed catch-slip behavior indicating the 
stiffening could be due to CD4 synergy. On the other hand, weaker ligands did not show 




 T cells showed similar curve in force 
vs. bond lifetime analysis. Only weak agonist T72 showed small catch-slip behavior but 
the rest showed slip-only behavior. Together, agonist dependent CD4 synergy to TCR–




Figure 4.7: Molecular bond stiffness analysis of 3.L2 T cellsHistogram (grey bar 
graph) of the molecular bond stiffness for APLs are plotted for CD4
+
 (A, C, E, G) and 
CD8
+
 (B, E, F, H) 3.L2 T cells. The histograms are fitted with a single Gaussian 
distribution (black line) except Hb binding to CD4
+
 T cells which had better fit with sum 
of two Gaussian distribution (A, green and cyan line). The least mean square method was 
used to fit all the data to a single constraint mean of the indicated spring constant. 
Goodness of fit for each fitting is calculated in R
2
. The sample size for each condition is 
listed as following: CD4
+
 Hb (n=173), CD4
+
 T72 (n=71), CD4
+





 Hb (n=45), CD8
+
 T72 (n=86), CD8
+
 I72 (n=66), and CD8
+
 A72 (n=59). 
 
Figure 4.8: Force vs. bond lifetime analysis of 3.L2 systemThe force-clamp assay data 
are analyzed with force vs. bond lifetime curve. The strong agonist Hb shows CD4 
dependent catch-slip behavior (A) whereas the weaker ligand does not show any CD4 
synergy (B). Only weak agonist T72 shows small catch-slip behavior and the rest 
antagonists, I72 and A72, show slip-only behavior. Filled symbols represent the data 
from CD4
+
 T cells and open symbols represent CD8
+
 T cells or CD4 blocking conditions. 
The sample size for each condition is listed as following: CD4
+





 I72 (n=221), CD4
+
 A72 (n=153), CD8
+
 Hb (n=129), CD8
+
 T72 (n=255), 
CD8
+
 I72 (n=182), and CD8
+
 A72 (n=151). 
 
 In order to test how force change the correlation of the bond lifetime to the ligand 
potency, we plotted the correlation curve between bond lifetime and the ligand 
concentration required to generate 40% B cell apoptosis (EC40) from the previous 
research
83
 (Figure 4.9). Like previously mentioned in zero-force correlation, the 
correlation of bond lifetime to EC40 only showed compressed correlation. In addition, the 
trend did not change much with (green) or without (blue) CD4 presence (Figure 4.9). 
However, when we correlate the bond lifetime at 10pN (force where the longest bond 
lifetime was observed) to EC40, the correlation expanded a little allowing better dynamic 
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range than the zero-force. Also, the presence of CD4 (red) increased the expansion of the 
correlation allowing better dynamic power.    
 Further to answer how force contributes to the power of ligand discrimination, we 
plotted bond lifetime ratio of Hb/other peptide vs. force (Figure 4.10). The analyses for 
I72 (green) and A72 (blue) show that the ratio of bond lifetime increases till 10-15pN 
regime then decrease. This trend was similar but had slight difference when considering 
CD4. In the case of where CD4 was present the maximum ratio of bond lifetime for I72 
was 1.5 times higher and for A72 1.6 times higher than the case where there was no CD4. 
For T72, the ratios of bond lifetime were lower compared to I72 and A72. These results 
further support that the force and the CD4 increases the power of ligand discrimination.  
 
 
Figure 4.9: Bond lifetime vs. functional EC40 analysis of 3.L2 systemThe correlation 
between bond lifetime and the ligand concentration required to generate 40% B cell 
apoptosis (EC40) from the previous research
83
 show that force can expand the dynamic 
range of the correlation. The mean bond lifetime for Hb (filled circle), T72 (filled 
triangle), I72 (open square), and A72 (open triangle) are plotted with fitted lines for 





Figure 4.10: Bond lifetime ratio of TCR bonds with Hb to anther pMHC vs. force 
analysis of 3.L2 systemThe ratio of bond lifetime of Hb/other pMHC vs. force show 









 (B) T cell population show increase of ratio for Hb/I72 (green) and Hb/A72 (blue). 
However, the magnitude of the ratio amplifies when there is CD4 (A). The data points 
from force vs. bond lifetime (Figure 4.8) were used to calculate the ratio.  
 
4.3 Discussion 
 In this chapter, we took the advantage of micropipette apparatus to quantify in situ 
2D kinetics and force-regulation of TCR–pMHC interaction and to correlate the 
measurements with those of the T cell function in a MHC class II-restricted system 
(3.L2) ( 
Table 3). Similar to the previous 2D kinetic measurements on a MHC class I-restricted 
system (OT-I)
1
, the 2D kinetic parameters of the 3.L2 system had a wider dynamic range 
than the 3D kinetic parameters in terms of their correlation to ligand potency. Also, the 
measured 2D binding predicted T cell responses better than 3D binding. Even though the 
dynamic power was smaller in the 3.L2 system than the OT-I system, the 2D kinetic 
parameters correlated better with ligand potency than that of the 3D. When tested under 
force, 3.L2 system showed qualitative difference in the tested panel of altered peptide 
ligands. Force prolonged TCR–pMHC interaction for the strong agonist but not for the 
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weaker ligands. Lastly, CD4 synergistically contributed to TCR–pMHC interaction only 
under force for the strong agonist.  
 
Table 3: Summary of 2D, 3D kinetics, and force-regulation of 3.L2 system 
 
  
 Recently, studies on 2D kinetics of the TCR–pMHC measurements using 
micropipette adhesion frequency assay have been well established. Other than previously 
mentioned studies on OT-I system
1, 40, 41
, Sabatino et al.
42
 used the micropipette adhesion 
frequency assay to detect the kinetics of polyclonal pMHC tetramer positive and negative 
CD4
+
 cells that were responsive in self MOG35–55 and pathogen GP61–80 epitopes. This 
study showed that the micropipette adhesion frequency assay had better detection 
capabilities than 3D pMHC tetramer kinetic methods which rely on multivalent 
interaction (TCR avidity). Also, Adams et al. 
43
 used the micropipette adhesion frequency 
assay to detect difference in docking geometric in TCR–pMHC and found better 
correlation of 2D affinity with IL-2 activation than 3D tetramer affinity. Most recently, 
Liu et al.
89
 reported 2D parameters of TCR–pMHC–CD8 interactions determine T cell 
tumor reactivity and suggested the possibility of 2D-based screening strategy for tumor 
immunotherapy. Overall, these findings show 2D kinetics have increased sensitivity than 
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3D kinetic measurements, and more accurately reflects the biology associated with T cell 
responses to antigen. 
 In addition to our observation, other previous studies also indicated different 
trends between the 2D and the 3D measurements
1, 43
.  For example, the agonist peptides 
show high binding affinities, fast off-rates and on-rates in the 2D measurements but high 
binding affinities, low slow off-rates and on-rates in the 3D. These differences in binding 
kinetics between 2D and 3D for the same molecules raise unanswered questions
90, 91
.  We 
believe that the different experimental conditions between the 2D and the 3D are 
beginning to provide some clues for these differences. For example, the 2D 
measurements are from membrane lipid anchored molecules that can be regulated by 
cytoskeleton and other proteins that can provide clustering or cooperativity between 
molecules. In contrast, the 3D measurements are typically from truncated forms of 
recombinant purified soluble molecules analyzed under conditions in flow that may not 
replicate the in situ molecular interaction. The importance of considering cellular 
microenvironment is supported by the recent cell-free 2D measurements that showed just 
the similar trend as the 3D measurements
92
. Although, off-rates have same unit of 
reciprocal time in both the 2D and the 3D, the direct conversion of on-rates and affinities 
between the 2D and the 3D is impossible due to different space dimensions of interacting 
molecules. This is an active area of research that would provide great insight into T cell 
triggering and response to antigens, but the direct conversion between 2D and 3D will be 
only possible when we can quantitatively measure the contribution of the cellular 
microenvironment in TCR–pMHC interaction. 
 Despite having similar TCR (~150 molecules/μm
2
) and co-receptor (~300 
molecules/μm
2
) density on a T cell surface, the dynamic range of 2D kinetic parameters 
in the 3.L2 and the OT-I system showed discrepancies. The 2D kinetics of the 3.L2 had a 
single-log distribution that correlated to a six-log magnitude difference in the functional 
parameters. This trend in 3.L2 system differs from that in the OT-I system, which had 
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three orders of magnitude difference in 2D kinetics correlating to six orders of magnitude 
in T cell proliferation
1
. Compared to the OT-I system, the correlation of the 3.L2 system 
has lower dynamic range (i.e., compressed kinetics). The compressed 2D kinetics of the 
3.L2 system seems unusual compared to the OT-I system, but this compactness was also 
observable in the 42F3 TCR system interacting with QL9:H2-L
d
 (MHC class I)-derived 




 for 2D effective affinity
43
. Although the difference 
in dynamic range is difficult to comprehend, we know the mouse systems are different 
with different MHC class restriction, associating co-receptor, and maybe different surface 
organization.  
 We wanted to compare the binding characteristics of CD4 to that of CD8
40, 41
.  





which was lower than that of CD8–H-2K
b













. Moreover, unlike CD8, CD4 did not exhibit a cooperative binding 
property
41
 in the binding frequency assay, nor did it show any contribution to an increase 
in the binding frequency of TCR–pMHC. Even with more sensitive detection method we 
could only confirm that CD4 has minimal contribution in TCR–pMHC interaction under 
zero-force.  
 However, when force was applied to TCR–pMHC interaction, CD4 showed 
synergistic effect to prolong the lifetime with the strong agonist. From the stiffness 
analysis, the strong agonist binding data showed a two Gaussian distribution fit which 
indicated two populations in the molecular bond formation. This was verified from force 
vs. bond lifetime curve analysis where CD4 strengthened the catch-slip behavior. For the 
other weaker ligands, CD4 synergy was not observed. In addition, ligand dependent 
qualitative behavior was observed under force. Agonists showed catch-slip behavior with 
different peak lifetime whereas antagonists showed slip-only behavior that further 
allowed qualitative distinction based on the ligand potency. Lastly, the two bond lifetime 
related analyses we performed show force and CD4 increase dynamic range of 
 
 56 
correlation to T cell function and increase the power of ligand discrimination. These 
results suggest that force in combination with CD4 enhances discrimination of the ligand 
potency by altering TCR–pMHC bond lifetime. Therefore, it is plausible to propose 
force-regulated TCR–pMHC interaction amplifies ligand discrimination and CD4 may 
have synergistic contribution.  
 In summary, we quantified the TCR–pMHC interaction in a cellular context for 
an MHC class II-restricted TCR system. Were we not only able to measure the 2D kinetic 
parameters but also were able to correlate the parameters to the T cell function. In 
addition, we found that because of their dynamic range, 2D kinetics were better able to 
distinguish ligand potency than 3D kinetics further supporting 2D kinetics as a reliable 
predictor of T cell function. We were not able to measure neither 2D kinetics nor 
cooperativity of CD4 in zero-force condition but when force was applied to TCR–pMHC 
interaction CD4 showed synergy in TCR–pMHC bond lifetime for a strong agonist. 
Lastly, force-regulated TCR–pMHC interaction showed qualitative ligand discrimination. 
This study supported a method of quantifying the receptor-ligand interaction under 
physical force and correlating the values with the cellular function that will enable us to 
continue research in an effort to explain the T cell recognition mechanism. 
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CHAPTER 5  CONSTRASTING CONTRIBUTION OF CO-
RECEPTORS AND 2D KINETICS  IN NAÏVE T CELLS AND 
THYMOCYTES 
5.1 Introduction 
 Previous studies reported high sensitivity of thymocyte in inducing positive 
selection by either recognition of low dose
93, 94
 or low affinity antigens
33, 47
. Also, pre-
selection DP thymocytes but not SP T cells were responsive to a weak agonist antigen in 
CD69 up-regulation and calcium mobilization
95
. In addition to higher sensitivity in 
thymocytes, CD8 binds more avidly
96, 97
 and enhances CD69 up-regulation and IL-2 
production with weak agonists (lower affinity ligands)
2-4
. On the other hand, CD4 
contribution may not be so dominant since positive selection can be possible in the 
absence of CD4
98
. Therefore, we anticipated to test the hypothesis of “TCR–pMHC 
interaction and co-receptor contribution may be different in naïve T cells and 
thymocytes.” Three specific aims are tested: 1) Quantify and compare 2D kinetic 
parameters of 3.L2 and OT-I TCR binding to its respective APLs in naïve T cells and 
thymocytes; 2) Compare the contribution of co-receptors in TCR–pMHC interaction for 
these systems; 3) Measure intracellular calcium signaling to compare the sensitivity 
between naïve T cells and thmocyctes. 
 In this chapter, we measured and compared 2D kinetics of TCR–pMHC–
CD4/CD8 binding on naïve T cells and DP thymocytes both in a MHC class I (OT-I)- or 
II (3.L2)-restricted systems. We used native DP thymocytes purified from a thymus of a 
transgenic OT-I or 3.L2 mouse. To derive the 2D binding kinetics, the altered peptide 
ligands were tested in the micropipette apparatus. The results showed that DP thymocytes 
had higher affinity than the naïve T cells. Also, in DP thymocytes CD8 contributed 
significantly from the early binding allowing no second step but a gradual contribution. 
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Consistent with the previous naïve OT-I data, CD8 cooperativity in DP thymocytes was 
signal dependent. However, CD4 did not show any contribution in TCR-pMHC binding 
in DP thymocytes. Lastly, concurrent calcium imaging with adhesion frequency assay 
showed higher sensitivity in DP thymoctes than naïve T cells. 
 
5.2 Results 
5.2.1 2D kinetic measurements of DP thymocytes 
 To compare the binding characteristics of DP thymocytes and naïve T cells, 
adhesion frequency assay was conducted to measure 2D kinetic parameters of DP 
thymocytes. DP thymocytes were purified from the thymus of 3.L2 and OT-I system as 
described in Materials and Methods. For 3.L2 system, we measured adhesion frequency 
level for APLs that were tested for naïve T cells in the previous chapter. The effective 2D 





times higher magnitude than that of  the naïve T cells (Figure 5.1A). 2D off-rates (2.17-
4.29 s
-1
) showed little difference from that of the naïve T cells (Figure 5.1B). 2D on-rates 






) showing 10-times higher 
magnitude than that of the naïve T cells (Figure 5.1C). Except I72 that showed an outlier 
trend, 2D measurements in thymocytes also showed correlation with the ligand potency 
similar to that of naïve T cells. 
 Similarly, effective 2D affinity of APLs in DP OT-I thymocytes ranged more than 
10-times higher than that of naïve T cells. The spectrum of effective 2D affinity of DP 









) (Figure 5.2). Therefore, we 
were not only able to quantify 2D affinity in thymocytes and naïve T cells but also 





Figure 5.1: Comparison of 2D measurements in naïve and DP 3.L2 thymocyteThe 
adhesion frequency assay for DP 3.L2 thymocytes was conducted through a panel of 
peptides (Hb64-76, T72, I72, and A72) to derive effective 2D affinity (A), effective 2D on-
rate (B), and 2D off-rate (C). The measured data were compared to that of the previously 
measured naïve T cells. Each 2D kinetic measurement is presented as mean ± SEM (n≥3).  
 
 
Figure 5.2: Comparison of effective 2D affinity in naïve and DP OT-I thymocyteThe 
adhesion frequency assay for naïve and DP OT-I thymocytes was conducted through a 
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panel of peptides (OVA, A2, Q4, Q4R7, T4, Q4H7, Q7, G4, E1, R4, and VSV) to derive 
effective 2D affinity. Each 2D kinetic measurement is presented as mean ± SEM (n≥5). 
 
5.2.2 Co-receptor contribution in DP thymocytes 





, the IL-2 production for agonist peptides
100
, the dimerization of the TCR-
pMHC complex
101
, but not significantly to the TCR binding energy
82
. In Chapter 4, 
however, CD4 did not contribute to TCR–pMHC interaction under zero-force. To further 
confirm the lack of CD4 cooperation on TCR–pMHC interaction, we conducted an 
adhesion frequency assay with and without blocking TCR and CD4 in 3.L2 DP 
thymocytes. We tested the effects of blocking TCR and CD4 by pre-incubating DP 
thymocytes with the anti-3.L2 clonotypic antibody (CAb) and the CD4 blocking antibody 
(GK1.5) and then performed the adhesion frequency assay against Hb64-76:I-E
k
-coated 
RBCs in the presence of the antibody in the experiment chamber. Adhesion frequency 
data showed that the GK1.5 treatment did not alter the binding frequency (Figure 5.3A). 
In contrast, the binding frequency disappeared when the cells were treated with CAb for 
Hb (Figure 5.3B). Therefore, consistent with the previous finding from naïve T cells, we 






Figure 5.3: Contribution of CD4 in adhesion frequency of 3.L2 thymocytesNo 
difference was observed in the adhesion frequency for the case of Hb and CD4 blocking 
(GK1.5) with Hb (A). However, CAb treatment resulted in a drop in the binding 
frequency (B). The irrelevant peptide MCC88-103:I-E
k
 with high density did not show 





): Hb64-76 (6:127),  Hb64-76 + GK1.5 (6:127), Hb64-76 + CAb 
(6:127), MCC (2:5552, 86 for CD4). Each binding frequency measurement is presented 
as mean ± SEM (n≥3) for 50 touches each. The data are representative from at least two 
independent experiments. 
 
 Previously, Jiang et al.
41
 found that CD8 synergistically enhances TCR-pMHC 
binding in naïve T-cells by observing a cooperative binding phenomenon in the adhesion 
frequency assay after one-second contact time. After CD8 formed a trimeric interaction 
with TCR–pMHC, the binding frequency increased abruptly (step-increase). We 
questioned whether this phenomenon also took place in OT-I DP thymocyte TCR–pMHC 
binding, so we tested the effect of blocking CD8 by pre-incubating DP thymocytes with 
the anti-CD8 antibody (CT-CD8a) and then performed an adhesion frequency assay on 
DP thymocytes against OVA257-264:H-2K
b
-coated RBCs in the presence of the antibody in 
the experiment chamber. Our adhesion frequency data showed that the CD8 blocking 
treatment reduced the binding frequency in all the measured contact times (Figure 5.4). 
In addition, CD8 cooperativity took place even during short contact times (0.1-0.5s). 
However, early CD8 cooperativity distinctly differed from that of naïve T-cells, in which 
CD8 cooperativity took place only during the longer contact times (after 1s) but not 
during the short contact times
41
. In addition, we tested whether CD8 cooperativity in DP 
thymocytes was signal dependent as in naïve T-cells. We used a PP2 treatment to inhibit 
Lck
41
, which eliminated the contribution of CD8 to the TCR-pMHC binding frequency 
(Figure 5.4). The PP2 treatment abrogated the binding frequency to the same level as 
TCR binding to OVA257-264:H-2K
b 
α3A2. Therefore, CD8 in DP thymocytes contributed 
to the TCR-pMHC binding from the early binding stage depending on Lck signaling. 









) (Figure 5.2). 
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This quantitative observation of decrease in CD8 affinity due to development is already 
reported. Moody et al.
97
 reported with using tetramer studies that CD8–MHC-I avidity 
decrease due to developmentally programmed O-glycan modification controlled by 
ST3Gal-I sialyltransferase during maturation. 
 
 
Figure 5.4: Contribution of CD8 in adhesion frequency of OT-IAdhesion frequency 
assay were conducted to test the contribution of CD8 in TCR–pMHC interaction. 
Experiment with wild-type OVA which could allow TCR–pMHC–CD8 interaction 
showed the highest adhesion level. However, mutant OVA which lack the binding site for 
MHC–CD8 interaction show a decreased adhesion level. When we treated Srk kinase 
inhibitor PP2 in testing wild-type OVA, the adhesion frequency dropped to the level of 





): wild-type OVA (9:46),  mutant OVA (9:42), wild-type OVA + 
10μM PP2 (9:46). Each binding frequency measurement is presented as mean ± SEM 
(n≥3) for 50 touches each. The data are representative from at least two independent 
experiments. 
 
5.2.3 Concurrent calcium imaging and adhesion frequency assay in naïve and DP 
3.L2 thymocytes 
 In order to compare the sensitivity of naïve and DP thymocytes, concurrent 
calcium imaging system was implemented to the adhesion frequency assay (see Materials 
and Methods). Ratiometric readout of Fura2 for 10min time interval was normalized for 
continuous RBC and T cell binding with indicated contact duration (Figure 5.5). 0.5, 1, 2, 
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and 5s contact duration conditions were tested with indicated average adhesion frequency 
(Figure 5.5). However, the normalized Fura2 ratio did not show increase upon 
continuous adhesion events. Only for long contact duration, 5s and continuous 
engagement, it showed 20% increase in Fura2 ratio after 9min.  
 However, when we tested DP 3.L2 thymocytes the Fura2 showed significant 
difference to the results from naïve T cells. Same experiment with 3.L2 thymocytes 
resulted in much more fluctuation and increase in Fura2 ratio with similar level of 
adhesion frequency. For example, more than 30% increase in Fura2 ratio was observed 
just 3min after initial binding event for 5s contact duration condition (Figure 5.6). Other 
conditions also showed earlier increase of Fura2 ratio with magnitude reaching higher 
than that of naïve T cells. These results indicate that thymocytes are more responsive in 
fluxing calcium after TCR–pMHC engagement than naïve T cells, which further support 





Figure 5.5: Normalized Fura2 ratio of naïve 3.L2 T cellsNormalized Fura2 ratios of 
naïve 3.L2 T cells were measured from concurrent calcium imaging system in 
combination with adhesion frequency assay. Averaged normalized Fura2 ratios (mean ± 
SEM) from number for different cell pairs of different contact durations are plotted with 
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respective average adhesion frequency. We took images every 8s for 1min before the 
initial adhesion event (black arrow) and continued for 9min.  
 
 
Figure 5.6: Normalized Fura2 ratio of DP 3.L2 thymocytesNormalized Fura2 ratios of 
FP 3.L2 thymocytes were measured from concurrent calcium imaging system in 
combination with adhesion frequency assay. Averaged normalized Fura2 ratios (mean ± 
SEM) from number for different cell pairs of different contact durations are plotted with 
respective average adhesion frequency. We took images every 8s for 1min before the 
initial adhesion event (black arrow) and continued for 9min. 
 
5.3 Discussion  
 In this chapter, we successfully characterized the contribution of co-receptors in 
the TCR–pMHC–CD4/CD8 trimolecular interaction in thymocytes (in both MHC class I 
and II systems) and compared their contributions to naïve T-cells. Whereas CD4 did not 
contribute to TCR–pMHC interaction under zero-force, CD8 had signaling dependent 
early cooperativity and its 2D affinity on thymocytes was higher than that on naïve T 
cells. We also quantified the TCR–pMHC bimolecular interaction in DP thymocytes by 
effective 2D affinity and compared it to that of naïve T-cells. Our results showed the 
effective 2D affinity of all of the tested TCR–pMHC bimolecular interactions was about 
 
 65 
10-times higher in DP thymocytes than in naïve T-cells. Lastly, concurrent calcium 
imaging demonstrated thymocytes were easier to stimulate than naïve T cells.  
 We know from flow cytometry analysis that even though the CD8 expression 
level of DP thymocytes is similar (~300/μm
2
) to that of naïve T-cells, the TCR expression 
level of DP thymocytes is around 10-times lower (several tens of molecules/μm
2
) than 
that of naïve T-cells. Based on this, it is questionable how thymocytes detect the ligand 
and initiate TCR signaling. In this context, higher 2D affinity of TCR–pMHC interaction 
in thymocytes and cooperativity of CD8 implies new information. Based on these data, 
we hypothesize that in contrast to naïve T-cells, DP thymocytes may compensate low 
level of TCR expression by higher affinity of TCR and early cooperativity of CD8 to 
have sufficient sensitivity for ligand recognition. For weaker ligands having similar or 
lower affinity than CD8, CD8 may even play a dominant role in TCR–pMHC recognition. 
We speculate these differences in thymocytes and naïve T-cells membrane may due to 
changes in composition or structural conformation of CD8 or TCR–CD8 complex during 
maturation. However, more in-depth research is required for verification.  
 More fundamental question in thymocyte context such as the mechanism of 
thymic selection can be asked. It has already been suggested that a 3D kinetic cutoff 
threshold correlates with negative selection
33, 52, 53
. However, for previously mentioned 
reasons 3D measurements may over simplify the physiologic TCR–pMHC interaction. 
Taking the advantage of 2D kinetics measurements, we can measure the 2D kinetics of 
DP thymocytes and relate them to the selection process to characterize how DP 
thymocytes quantify selection cues. Investigations related to this regard have been 
followed up in Chapter 6.  
 The study in this chapter showed a unique method of characterizing and 
quantifying the TCR–pMHC interaction in DP thymocytes in a cellular context. We were 
able to characterize the signaling-dependent CD8 cooperativity but not with CD4. In 
addition, we demonstrated higher sensitivity of TCR–pMHC interaction in thymocytes 
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with 2D affinity and concurrent calcium imaging. The findings of this study provide 





CHAPTER 6  FORCE-REGULATED BOND LIFETIME OF TCR–
pMHC INTERACTION DETERMINES THYMIC SELECTION 
6.1 Introduction 
 The repertoire of TCRs in the periphery is thought to be derived from thymocytes 
that have been selected from thymus by an optimal binding affinity window
10
. T cells 
with TCR that does not bind to self antigens die by neglect and those that bind too 
strongly undergo apoptosis to prevent potential autoimmune response. Only the T cells 
with optimal affinity TCR are positively selected. In this context, previous literature also 
suggests apparent affinity threshold for negative and positive selection discrimination
53
. 
Several approaches have been conducted to identify the thymic selection parameter such 
as kinetic threshold
33, 52-54
, CD3 conformational change
56-59
, signaling kinetics and 
compartmentalization
44, 52
. However, we only know that subtle differences in kinetics (i.e., 
less than two-fold difference in the selection border) or CD3 conformational change lead 
to distinct downstream signaling. In this chapter, we anticipated to test the hypothesis of 
“in situ 2D kinetics and force regulation of TCR–pMHC interaction better define thymic 
selection.” This hypothesis is based on previous studies
1, 39
 and our previous chapters that 
show 2D kinetic measurement better represent TCR–pMHC interaction. In addition, force 
could play a critical role in TCR–pMHC interaction due to continuous migration of 
thymocytes in thymus by encountering cortical (cTEC) and medulla thymic epithelial 
cells (mTEc)
5
. Three specific aims are tested: 1) Quantify zero-force 2D kinetic 
parameters of immature TCR–pMHC interaction in thymic selection; 2) Analyze force 
regulation in TCR–pMHC interaction in thymic selection; 3) Verify force regulation 
effect in thymic selection with endogenous ligands and in an alternative system.  
 In this chapter, we implemented mechanically based micropipette assays to study 
TCR-pMHC interaction considering co-receptor contribution and mechanical force 
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regulation in a native thymocyte environment to identify better physiologic predictor for 
thymic selection. We used negative and positive selecting ligands for transgenic OT-I 
mouse system to measure 2D binding characteristics, molecular bond stiffness, and force-
lifetime relationship with micropipette apparatus
73, 76
. Our results show that normalized 
adhesion bonds, 2D effective affinity for TCR–pMHC, and zero-force synergy of CD8 do 
not show any significant difference among the tested ligands. However, when we applied 
force on the TCR–pMHC interaction we were able to observe significant difference 
between the two selecting ligand groups. Negative selecting ligands showed a catch-slip 
behavior (i.e., force induce longer lifetime until some degree then force induce shorter 
lifetime afterwards). On the other hand, positive selecting ligands showed only a slip 
behavior (i.e., force induce shorter lifetime). For verification, an alternative mouse 
system (2C) and endogenous peptide sequences were tested to demonstrate the same 
result. Based on these findings, we predict force induce longer lifetime for negative 
selecting ligands that can promote enough interval for signal initiation or accumulation 
for further downstream signaling. However, for positive selecting ligands force shortens 
bond lifetime restricting signaling to occur or accumulate. These results show a novel 




6.2.1 Zero-force 2D kinetic measurements in thymic selection  
 In order to test correlation between 2D kinetics and thymic selection, we first 
anticipated to implement 2D adhesion technique to test a panel of pMHCs for a clear 
separation in 2D adhesion or kinetic parameters. For this purpose, we tested a panel of 
pMHCs (OVA, Q4, Q4R7, T4, Q4H7, Q7, and G4) that have been previously reported by 
Ed Palmer group
52, 53
  that showed strong correlation in FTOC to negative (OVA, Q4, 
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Q4R7, and T4) and positive selection (Q4H7, Q7, and G4) (Figure 6.1). We used 
micropipette adhesion frequency assay to test the adhesion characteristics of these 
pMHCs to OT-I thymocytes (Figure 6.2). Since TCR and CD8 can both bind to pMHC 
on native thymocyte surface, we selectively tested TCR–pMHC interaction only by using 
either anti-CD8 blocking antibody (green triangle) or mutant MHC-I (H-2K
b
 α3A2) that 
limits CD8 binding to MHC-I (brown circle). Also, we tested TCR contribution in 
binding frequency by using anti-TCR blocking antibody (red diamond).   
 
Figure 6.1: APLs for thymic selectionPercentage of CD8 single-positive thymocytes 
generated in FTOC as a function of normalized ligand potency of OT-I system (adapted 




 To compare directly among different ligands, binding frequency at each time 
point was converted to average adhesion bonds <n> = -ln(1 – Pa) and normalized by 
pMHC density ml for normalized adhesion bonds (Figure 6.4), or fitted by the 
probabilistic kinetic model )}]exp(1{exp[1 coffaclra tkKAmmP 
1, 41, 73
 for effective 2D 
affinity (Figure 6.3B). As expected, normalized adhesion bonds (Figure 6.4A and B) 
and effective 2D affinity (Figure 6.3B) of MHC–CD8 measured from VSV ligand were 
lower than those of the other ligands where OVA showed the strongest normalized 






Figure 6.2: Adhesion frequency analysis in thymic selectionAdhesion frequency assay 
for negative and positive selecting ligands were performed for four different conditions: 
wild-type H-2K
b
 (blue square), H-2K
b
 α3A2 (brown circle), wild-type H-2K
b
 in the 
presence of CD8 blocking antibody (CT-CD8a, green triangle), and wild-type H-2K
b
 in 
the presence of TCR blocking antibody (B20.1, red diamond). Similar level of pMHC 
density was used to compare measurements for indicated conditions in each ligand. 
However, the measurements for TCR–pMHC interaction in Q4-G4 (brown circle and 
green triangle) were not detectable with these pMHC densities. CD8–MHC interaction 
(red diamond) showed little lower level of binding frequency to the TCR–pMHC–CD8 
trimolecular interaction (blue square). Each binding frequency measurement is presented 
as mean ± SEM (n≥3) for 50 touches each. The data are representatives from three 
independent experiments.   
 
 To measure 2D off-rate of TCR–pMHC interaction, we conducted thermal 
fluctuation assay with biomembrane force probe (BFP)
84
 (Figure 6.3A). The slope of 
bond lifetime distribution yielded 2D off-rate from a first-order dissociation kinetics
1
. 
Whereas the 2D off-rate correlated inverse to the ligand potency (grey bar, Figure 6.3C), 
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the effective 2D on-rate (white bar, Figure 6.3C) tracked with the effective 2D affinity 
(grey bar, Figure 6.3B) both correlating with the ligand potency.  
 
 
Figure 6.3: Thermal fluctuation assay and 2D kinetics analysis in thymic 
selectionFor 2D off-rate of TCR–pMHC interaction, thermal fluctuation assay was 
conducted with peptides bound to H-2K
b
 α3A2 (A). From the slope of distribution of 
bond lifetime, we can yield off-rates using first-order dissociation kinetics
1
. In addition, 
effective 2D affinities for the selecting ligands in naïve (white bar) and DP thymocytes 
(grey bar) are derived from adhesion frequency for comparison (B). Previous 3D affinity 
data (striped bar) using tetramer staining is plotted together for comparison
52
. The 
measured 2D off-rate and calculated effective 2D on-rate is plotted in bar graph for 
comparison among selecting ligands (C). Colored letters indicate thymic selection 
readout: red (negative selection), grey (selection threshold), and blue (positive 
selection)
52
. The sample size of bond lifetime for each ligand in thermal fluctuation data 
is listed as following: OVA (n=52), Q4 (n=39), Q4R7 (n=49), T4 (n=26), Q4H7 (n=31), 
Q7 (n=39), G4 (n=52), and VSV (n=20).Each bar in the effective 2D affinity is presented 
as mean ± SEM (n≥5).  
 
 For TCR–pMHC–CD8 trimolecular interaction, we calculated normalized 
adhesion bonds
41
  by converting the adhesion frequency at the plateau level Pa to average 
adhesion bonds <n> = -ln(1 – Pa) and normalizing it by pMHC density ml (white bar, 
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Figure 6.4B) as well as the sum of normalized TCR–pMHC and MHC–CD8 bonds
73
 by 
multiplying their effective 2D affinities by their respective TCR and CD8 site densities 
(grey bar, Figure 6.4B). The difference between the white and grey bar represents the 
synergy for the TCR–pMHC–CD8 trimolecular interaction for that ligand (Figure 6.4C). 
The larger the difference, the greater the synergy generated by the TCR–CD8 cooperation 
for pMHC binding
41
. Weaker ligands generated larger synergy than the strongest ligand 
OVA but their normalized adhesion bonds had no significant difference (p>0.5, one-way 
ANOVA). In summary, although the in situ 2D measurements were sensitive to detect 
bimolecular and trimolecular interaction in weaker ligands such as G4 and Q7, the 
dynamic range was comparable to the 3D measurements
52




Figure 6.4: Normalized adhesion bonds and  synergy analysis in thymic selectionFor 
direct comparison among different ligands, adhesion frequency data can be normalized 
by the pMHC density to yield normalized adhesion bonds. Except OVA, other selecting 
ligands have no significant difference in the time curve (A) or at the saturation level 
(white bar, B). To dissect the contribution in bond interactions, normalized adhesion 
bonds were measured from following conditions: pMHC with H-2K
b
 (mixture of TCR–
pMHC–CD8, TCR–pMHC, and MHC–CD8),  pMHC with H-2K
b





  (MHC–CD8). Assuming these interactions occur independent to each 
other, <ntotal>/ml = <nTCR–pMHC>/ml + <nCD8–MHC>/ml + <nsynergy>/ml
41
. The synergy of CD8 
(C) can be calculated from the difference between the white bar and the grey bar from B. 
Previous 3D avidity data using tetramer staining is plotted together in B for comparison
52
. 
Colored letters indicate thymic selection readout: red (negative selection), grey (selection 
threshold), and blue (positive selection)
52
. Each point in the normalized adhesion bonds is 
presented as mean ± SEM (n≥3). The data are representatives from three independent 
experiments. 
 
6.2.2 Molecular bond stiffness analysis and force-clamp assay in thymic selection 
 In addition to the importance of considering TCR–pMHC interaction in a 2D 
membrane surface, several recent studies have indicated that TCR recognize physical 
force to activate T-cells
38, 85-88
. For thymocytes, migration (10~20 μm/min) in cortex and 
medulla microenvironments, and continuous scanning on thymic epithelial cells can 
possibly exert physical force to TCR–pMHC interaction
5
. In addition, actin 




 We therefore first analyzed the molecular bond stiffness from the slope of the 
ramping phase of bond events in BFP force-clamp assay. The distributions of measured 
molecular bond stiffness were then fitted to either single or sum of two-Gaussian 
distributions using least mean square method to find the best parameter for fitting. The 
data demonstrated two distinct patterns separated by negative and positive selecting 
ligands. The histogram of molecular bond stiffness of O-T4:H-2K
b
 fitted well with sum 
of two-Gaussian distribution (Figure 6.5A, B, C, and D) that had constraint 
mean1=0.17pN/nm and mean2=0.51pN/nm. On the other hand, Q4H7-G4:H-2K
b
 fitted 
well with single Gaussian distribution (Figure 6.5E, F, G, and H) with a constraint 
mean=0.17pN/nm. However, when we tested the same analysis in the case of peptides 
bound to H-2K
b
 α3A2 the histogram of molecular stiffness for all ligands fitted with 
single Gaussian distribution (Figure 6.6) indicating the rise of the second population 





Figure 6.5: Molecular bond stiffness analysis in thymic selection with H-2K
b
The 
molecular bond stiffness from the slope of the ramping phase of bond events in BFP 
force-clamp assay was collected for histogram analysis. The data fitted to either single or 
sum of two-Gaussian distributions using least mean square method to find the best 
parameter for fitting. Negative selecting ligands (OVA-T4) fitted well with sum of two-
Gaussian distribution with constraint mean1=0.17pN/nm and mean2=0.51pN/nm, whereas 
positive selecting ligands (Q4H7-G4) and irrelevant ligand (VSV) fitted well with single 
Gaussian distribution with a constraint mean=0.17pN/nm. Goodness of fit for each fitting 
is calculated in R
2
. Colored letters indicate thymic selection readout: red (negative 
selection), grey (selection threshold), and blue (positive selection)
52
. The sample size of 
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bond lifetime for each ligand is listed as following: OVA (n=192), Q4 (n=162), Q4R7 
(n=254), T4 (n=197), Q4H7 (n=95), Q7 (n=68), G4 (n=104), and VSV (n=131). 
 
 
Figure 6.6: Molecular bond stiffness analysis in thymic selection with H-2K
b
 α3A2In 
the case of neglecting CD8 binding to MHC by using H-2K
b
 α3A2, the stiffness 
histogram of all ligands fitted well with single Gaussian distribution with a constraint 
mean=0.17pN/nm. Goodness of fit for each fitting is calculated in R
2
. Colored letters 
indicate thymic selection readout: red (negative selection), grey (selection threshold), and 
blue (positive selection)
52
. The sample size of bond lifetime for each ligand is listed as 
following: OVA (n=99), Q4 (n=76), Q4R7 (n=98), T4 (n=52), Q4H7 (n=25), Q7 (n=34), 




 In the cases of two Gaussian fitting ligands with H-2K
b
, the fraction of two 
Gaussian distributions can be calculated to show increase in the fraction of the second 
(higher stiffness or synergy) population as the negative selecting power gets stronger 
(Figure 6.7A). Also average of bond stiffness showed stiffer spring constant for negative 
selecting ligands with H-2K
b
 (“total”, grey bar, Figure 6.7B). With knowing the fraction 
of synergistic TCR–pMHC–CD8 interaction and normalized adhesion bonds for TCR–
pMHC and CD8–MHC from adhesion frequency assay, we were able to calculate the 
stiffness of synergistic TCR–pMHC–CD8 interaction (ksynergy) to be around 0.6pN/nm 
(striped bar, Figure 6.7B).  
 
 
Figure 6.7: Fraction of synergy and average spring constant analysis in thymic 
selectionThe fraction of synergistic TCR–pMHC–CD8 interaction from stiffness analysis 
(A) and the average of molecular bond stiffness (B) are plotted for comparison in 
selecting ligands. Assuming bond interactions occur independent to each other, <ktotal> = 
<fraction of mean1 distribution in stiffness histogram>(<kTCR–pMHC><nTCR–pMHC>ratio/ml + 
<kCD8–MHC><nCD8–MHC>ratio/ml) + <fraction of mean2 distribution in stiffness 
histogram><ksynergy>. With knowing the fraction of synergistic TCR–pMHC–CD8 
interaction and normalized adhesion bonds for TCR–pMHC and CD8–MHC from 
adhesion frequency assay, ksynergy is calculated (striped bar). Colored letters indicate 





 Next, we measured force-lifetime relationships in thymic selection using force-
clamp assay
75, 76
. Like stiffness analysis, the result showed a selection-dependent 
characteristic. For TCR–pMHC–CD8 total interaction with H-2K
b
, negative selecting 
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ligands (OVA-T4) formed catch-slip bonds where lifetime first increased, reached a 
maximum around 13pN, then decreased with increasing force (green square, Figure 6.8A, 
B, C, and D). If tested with H-2K
b
 α3A2 that only allowed TCR–pMHC bimolecular 
interaction, the catch-slip bond phenomenon was weakened for negative selecting ligands 
(brown circle, Figure 6.8A, B, C, and D) indicating the importance of CD8 for these 
ligands. In addition, most distinct ligand separation was observed in lifetime distribution 
in the 10-15pN regime which includes the maximum peak. In sharp contrast, positive 
selecting ligands (Q4H7-G4) presented by whether H-2K
b
 (total) or H-2K
b 
α3A2 (TCR–
pMHC) formed slip bonds where lifetime was shortened by force (Figure 6.8), 
suggesting this type of force-dependent dissociation characteristics is important for 
peripheral exportation.  
 In fact, the lifetime measured with H-2K
b
 (total) include contributions from two 
bimolecular interactions, TCR–pMHC and CD8–MHC, and a synergistic TCR–pMHC–
CD8 interaction: <ttotal> = <fraction of mean1 distribution in stiffness histogram>(<tTCR–
pMHC><nTCR–pMHC>ratio/ml + <tCD8–MHC><nCD8–MHC>ratio/ml) + <fraction of mean2 
distribution in stiffness histogram><tsynergy>. Knowing the fraction of sum of bimolecular 
interactions and synergy, and normalized adhesion bonds from adhesion frequency assay, 
we can calculate lifetime of synergistic TCR–pMHC–CD8 interaction. Indeed, it shows a 
catch-slip bond for the negative selecting ligands (purple dash-line, Figure 6.8A, B, C, 
and D). To further support it is synergistic TCR–pMHC–CD8 interaction that derive 
catch-slip bond, only the bond lifetime events that had stiffness larger than the 
mean2=0.51pN/nm from stiffness analysis were analyzed for force-lifetime relationship 
(orange diamond, Figure 6.8). Likewise, these events showed catch-slip bonds in 
negative selecting ligands but not in positive selecting ligands. Whereas the synergy in 
normalized adhesion bonds had no distinguishing power under zero-force, under force the 
synergistic TCR–pMHC–CD8 interaction was crucial for catch-slip behavior in negative 




Figure 6.8: Force-lifetime analysis in thymic selectionFor TCR–pMHC–CD8 total 
interaction with H-2K
b
 (green square), negative selecting ligands (OVA-T4) formed 
catch-slip bonds whereas positive selecting ligands (Q4H7-G4) yielded slip bonds. 
However, in the case of Q4, Q4R7 and T4, both TCR–pMHC interaction with H-2K
b
 
α3A2 (brown circle) and CD8–MHC interaction with VSV:H-2K
b
 (black triangle) only 
demonstrated slip bonds. Assuming these interactions are independent, <ttotal> = <fraction 
of mean1 distribution in stiffness histogram>(<tTCR–pMHC><nTCR–pMHC>ratio/ml + <tCD8–
MHC><nCD8–MHC>ratio/ml) + <fraction of mean2 distribution in stiffness 
histogram><tsynergy>. With previously calculated fraction of sum of bimolecular 
interactions and synergy, and normalized adhesion bonds from adhesion frequency assay, 
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we can calculate lifetime of synergistic TCR–pMHC–CD8 interaction (purple dash-line). 
To further test the contribution of synergistic TCR–pMHC–CD8 interaction, selective 
analysis with bond events with >0.51pN/nm showed catch-slip bonds for negative 
selecting ligands but not with positive selecting ligands. Colored letters indicate thymic 
selection readout: red (negative selection), grey (selection threshold), and blue (positive 
selection)
52




































 In order to investigate more on the effect of force-prolonged bond lifetime, we 
separated the lifetime events into different force regimes (0-5, 5-10, 10-15, and 15-20pN) 
and plotted normalized bond lifetime distributions (Figure 6.9). This analysis allows 
comparison of number of bonds that can survive at certain bond lifetime. For instance, in 
0-5pN regime the trend of number of bond survival for the tested pMHCs show similar 
behavior (Figure 6.9A), but starting from 5-10pN regime negative ligands show longer 
survival than positive selecting ligands (Figure 6.9B). This trend of survival separation 
reaches peak at 10-15pN regime where all the negative selecting ligands show significant 
amount of bond survival even longer than 2s (Figure 6.9C). After reaching 10-15pN, the 
15-20pN regime shows less discrete separation in the number of bond survival due to 
drop of Q4, Q4R7 and T4 (Figure 6.9D). The same analysis with H-2K
b
 α3A2 (Figure 
6.9E, F, G, and H) showed overall similar trend to H-2K
b
 but the discrete separation of 
positive and negative selecting ligands was more obvious in 10-15pN of H-2K
b
. These 
results indicate force-prolonged bond lifetime increases the bond survival separation 












α3A2Normalized bond lifetime distributions are plotted in different force regimes (0-5, 
5-10, 10-15, and 15-20pN). This allows comparison of number of bonds that can survive 
at certain bond lifetime in selecting ligands. As force increases (A, B, C, and D) in H-2K
b
 
condition, the separation in the survival trend of selecting ligands are observed most 
discrete in 10-15pN (C). On the other hand, with H-2K
b
 α3A2 the separation is not so 
obvious (E, F, G, and H). Colored letters indicate thymic selection readout: red (negative 
selection), grey (selection threshold), and blue (positive selection)
52
. The sample size for 











































 of the number of bonds that survived 4s lifetime. We chose 4s as a 
conservative time point for initiation of signaling after TCR stimulation from previous 
research where LAT phosphorylation was observed in 4s after stimulation
10, 104
. The 
calculation show that indeed at 10-15pN ΔQ4R7-QH7 had three-times more bond 
number than that of other force regimes (Figure 6.10A).  
 In addition, bond lifetime distribution can be fitted with two-state model
76, 105
 for 
analysis of short-lived state and long-lived state. To investigate the contribution of long-
lived states, we plotted the average spring constant (Figure 6.10B) and force-lifetime 
relationship (Figure 6.10C) with long-lived state only for Q4R7, T4 and Q4H7. For 
Q4R7 and T4, average spring constant showed 0.6pN/nm and catch-slip bonds whereas 
Q4H7 showed 0.2pN/nm and slip bonds. These measurements and trends in force-
lifetime relationship coincide with the synergistic TCR–pMHC–CD8 interaction 
observed earlier.  Furthermore, probability can be calculated for the percentage of events 
that had stiff bond with long lifetime. The probability of stiffer and long lifetime events 
out of total stiffer events can be calculated by P(long LT | high stiff)  = P(high stiff | long 
LT) × P(long LT) / P(high stiff). Also, the probability of stiffer and long lifetime bonds 
out of total events can be calculated by P(high stiff | long LT) × P(long LT). The result 
show that both of the probabilities positively correlate to the power of the negative 
selection (Figure 6.10D). This further support the idea that force-induced synergistic 











 of number of bonds (ΔQ4R7-QH7) that survived 4s lifetime showed three-
times more bond number at 10-15pN regime than that of other force regimes (A). Fitting 
the bond lifetime distribution with two-state model allowed the analysis of long-lived 
states for average spring constant (B) and force-lifetime relationship (C). Lastly, 
probabilities are calculated for the percentage of events that had stiff bond with long 
lifetime. Colored letters indicate thymic selection readout: red (negative selection), grey 




 Further to answer how force contributes to the power of ligand discrimination, we 
plotted bond lifetime ratio of OVA/other peptide vs. force (Figure 6.11). In the presence 
of CD8, the analyses for negative selecting ligands (warm colors) and positive selecting 
ligands (cold colors) showed drastic discrimination with the highest separation occurring 
at 10-15pN regime. The difference in the ratio between negative and positive selecting 
ligands was 3 to 4 times at this force regime. However, in the absence of CD8 the ligand 
separation was not observed which further indicates that CD8 cooperativity under force is 




Figure 6.11: Bond lifetime ratio of TCR bonds with OVA to anther pMHC vs. force 
analysis of OT-I systemThe ratio of bond lifetime of OVA/other pMHC vs. force show 
increase power of ligand discrimination. The negative and positive selecting ligand show 
discrete separation in the presence of CD8 (A). However, in the absence of CD8, the 
strong separation of the ratio is not observed anymore (B). The data points from force vs. 
bond lifetime (Figure 6.8) were used to calculate the ratio. 
 
6.2.3 Verification of force regulation effect in thymic selection   
 In order to test our findings in more physiologic condition, endogenous ligands 
that have been identified previously to give positive selection in FTOC were tested in 
force-clamp assay. These results were further supportive to our findings as slip bonds 
were observed in endogenous positive selecting ligands, Catnb329-336 (β-catenin, 
RTYTYEKL) and Capp192-99 (F-actin capping protein A, ISFKFDHL)
67, 68
. When 
comparing endogenous peptides only, the difference in the force-regulated dissociation 
characteristics was more distinct between negative (OVA) and positive (RTYTYEKL and 





Figure 6.12: Force-lifetime analysis for endogenous ligands in thymic 
selectionConsistent with our previous finding, endogenous positive selecting ligands 
show slip bonds. Colored letters indicate thymic selection readout: red (negative 
selection) and blue (positive selection)
52












 To further verify our observation in an alternative TCR system, 2C TCR system 




, and positive 







Results from stiffness analysis, force-lifetime relationship, and bond lifetime distribution 
further supported our findings: the two negative selecting ligands showed CD8-dependent 
stiffer population in stiffness histogram (Figure 6.13A, B, and G) and catch-slip bond in 
force-lifetime relationship (Figure 6.14A and D) whereas the three positive selecting 
ligands showed no observation of stiffer population (Figure 6.13C, D, E, F, and H) and 
slip bond in force-lifetime relationship (Figure 6.14B, C, and D). Consistent with OT-I 
system, normalized bond lifetime distribution of 2C system showed discrete separation of 
negative and positive ligands at 10-15pN regime and the discrimination power dropped 








Figure 6.13: Molecular bond stiffness analysis in 2C systemThe molecular bond 
stiffness from the slope of the ramping phase of bond events in BFP force-clamp assay 
was collected for histogram analysis. The data fitted to either single or sum of two-
Gaussian distributions using least mean square method to find the best parameter for 
fitting. Negative selecting ligands (SIYR and dEV8:H-2K
bm3
) fitted well with sum of 
two-Gaussian distribution with constraint mean1=0.20pN/nm and mean2=0.55pN/nm (A 
and G), whereas positive selecting ligands (dEV8, EVSV, and p2Ca) (C, D, and H) and 
irrelevant ligand (VSV) (I) fitted well with single Gaussian distribution with a constraint 
mean. Goodness of fit for each fitting is calculated in R
2
. In the case of neglecting CD8 
binding to MHC by using H-2K
b
 α3A2 (B, D, and F), the stiffness histogram of all 
ligands fitted well with single Gaussian distribution with a constraint mean=0.20pN/nm. 
Goodness of fit for each fitting is calculated in R
2
. Colored letters indicate thymic 
selection readout: red (negative selection) and blue (positive selection)
35, 70-72
. The sample 
























Figure 6.14: Force-lifetime analysis in 2C systemFor TCR–pMHC–CD8 total 
interaction (green square), negative selecting ligands (SIYR and dEV8:H-2K
bm3
) formed 
catch-slip bonds whereas positive selecting ligands (dEV8, EVSV, and p2Ca) yielded slip 
bonds. The trend was similar in TCR–pMHC interaction (brown circle). Colored letters 
indicate thymic selection readout: red (negative selection) and blue (positive selection)
35, 
70-72
























Figure 6.15: Normalized bond lifetime distribution of pMHCs in 2C systemTo 
compare number of bonds that survive certain lifetime, normalized bond lifetime 
distributions are plotted in different force regimes (0-5, 5-10, and 10-15). The separation 
in the survival trend between the selecting ligands is observed as increasing force (A, C, 
and C). With H-2K
b
 α3A2, the separation is still present but in lower power than H-2K
b
 
(D, E, and F). Colored letters indicate thymic selection readout: red (negative selection) 
and blue (positive selection)
35, 70-72
. The sample size of bond lifetime for each ligand is 


















 (n=151), and VSV (n=112). 
 
6.3 Discussion 
 In this chapter, 2D kinetics that previously showed better sensitivity than the 3D
1, 
42
 was determined for thymic selection. However, neither the effective 2D affinity for 
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TCR–pMHC bimolecular interaction nor the normalized adhesion bonds or synergy for 
TCR–pMHC–CD8 trimolecular interaction showed sufficient differences among negative 
and positive selecting ligands that induce drastically different fates in T-cells. However, 
when force was applied to TCR–pMHC–CD8 interaction two distinct patterns emerged 
on bond stiffness histogram and force-dependent dissociation characteristics. For both 
engineered and endogenous peptides, negative selecting ligands had synergistic TCR–
pMHC–CD8 interaction that formed catch-slip bonds whereas positive selecting ligands 
did not have that population only to form slip-only bonds (summarized in Table 4).   
 
Table 4: Summary of OT-I and 2C system  
 
  
 Mechanosensing behavior of TCR has been previously reported. Judokusumo et 
al.
86
 showed a positive correlation of IL-2 production of naïve T cells with 
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polyacrylamide gel substrate stiffness. Kim et al.
53
 reported 50pN of tangential force on 
CD3 induced by optical trap could influx calcium for T cell activation. Li et al.
87
 reported 
shear and pulling force on CD3 complex using micropipette could influx calcium. In 
addition, some evidence even argue that upon TCR engagement force is generated
85
. 
Recently catch bond observed in antigen-specific TCR–pMHC interaction has been 
demonstrated to trigger T-cell signaling (Liu and Chen et al. accepted to Cell). Our 
conclusion from this chapter further supports the importance of force-regulated TCR–
pMHC bond interaction for thymic selection.  
 Other than our observation, the counter-intuitive characteristic of catch bonds are 













, and TCR (Liu and Chen et al. 
in press). Although specific detail of molecular mechanism of this behavior is still not 
fully understood, some models based on molecular dynamic simulation has been 
proposed to understand physiologic relevance
112
. In this regard, our finding of catch-slip 
bond in negative selecting ligands opens question for molecular mechanism and 
biological relevance. It could be possible that force with negative selecting ligands may 
increase bond lifetime to induce phosphotase segregation on the contact surface for 
favoring kinase activity (“kinetic segregation model”)
113
 and/or it may alter conformation 
of TCR-CD3 complex for access of Lck to the ITAMs
57
. Other possibility is that the 
force could alter membrane surface for actin remodeling that is required for initiation of 
full TCR signaling
114
. On the other hand, force on positive selecting ligands may only 
give sufficient bond lifetime for survival signaling.  
 In fact, two-photon microscopy study on thymocyte migration in medulla eludes 
some connection with single bond lifetime and cellular migration
115
. In the presence of a 
negative selecting ligand, thymocytes slowed down, became confined to a region of 
30μm in diameter where they had increased contact with surrounding dendritic cells
115
. 
Considering our findings, it is possible that the reduction of the speed of thymocytes and 
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confinement area could be due to prolonged bond lifetime due to force regulation. More 
related study is necessary for further understanding.  
 We know in force-free condition, CD8 on a naïve T-cell binds to TCR–pMHC 
cooperatively with 1s delay in a Srk kinase dependent way
41
. However, in DP thymocytes, 
CD8 cooperativity was observed as early as the shortest contact time tested (0.1s) but still 
in a signaling dependent manner as it was eliminated by the Src kinase inhibitor PP2. In 
addition, CD8 in DP thymocytes binds higher affinity to MHC-I possibly because of 
developmentally programmed O-glycan modification controlled by ST3Gal-I 
sialyltransferase
96, 97
. Also, regions for CD8 association to TCR (such as CD3δ and α-
CPM
59
) were identified to be critical in positive selection
58
. Based on these and our 
findings of CD8-dependent synergistic effect in force-regulated bond lifetime, we can 
imagine CD8 plays a critical role in thymic selection. It is plausible to propose the 
dominant expression level and early cooperativity of CD8 in thymocyte membrane can 
contribute significantly to the binding of self-pMHC, possibly acting as decision maker 
under force where newly binding sites are available to enhance strong binding for 
initiation of signaling events for negative selecting ligands but no such effect for positive 
selecting ligands. More careful experiments are necessary to test this hypothesis and to 
understand the mechanism.   
 The study in this chapter showed a novel observation in characterizing and 
quantifying the TCR–pMHC interaction in thymic selection. We were able to 
characterize CD8-dependent synergistic TCR–pMHC–CD8 interaction under force for 
negative selecting ligands but not for positive selecting ligands. The findings of force-






CHAPTER 7  CONCLUSIONS AND FUTURE DIRECTIONS  
 In this thesis, we showed that co-receptor and force regulated 2D TCR-pMHC 
interaction determine T cell function. We have tested two systems to show in the absence 
or presence of force what parameters influence the ligand discrimination for T cell 
activation or thymic selection. Using ultrasensitive 2D mechanical assays, in situ 2D 
kinetic measurements showed better sensitivity than the SPR 3D kinetic measurements in 
gauging the ligand potency and thymic selection. In addition, force-regulated bond 
lifetime of TCR–pMHC interaction amplified the discrimination of APLs and thymic 
selection. When force was applied to TCR–pMHC–CD4/8 bonds, two distinct patterns 
emerged: agonist/negative selecting ligands formed CD4/8-dependent catch-slip bonds, 
whereas antagonist/positive selecting ligands formed slip-only bonds. In thymic selection, 
CD8-dependent synergistic effect was critical for negative selection. We speculate that 
force-prolonged bond lifetime in agonist/negative selecting ligands may allow sufficient 
time window for signaling molecules such as Lck and Zap70 to accumulate to the TCR 
proximal for the cascade of downstream signaling events.  
 In continuation of this study, following questions could be addressed: 1) How 
would the signaling molecules accumulate in force-prolonged TCR-pMHC interaction; 2) 
What is the structural mechanism for synergistic TCR-pMHC-CD4/8 interaction under 
force; 3) How much physiologic force can T cell or thymocytes exert on TCR; 4) Is force 
critical in actually thymic selection; 5) How does force contribute to “agonist selection;” 
6) Can force contribute to on-rate change; 7) Is there CD4 synergy in thymic selection. 
 To test how force-regulated bond lifetime relate to T cell signaling, our colleagues 
have measured concurrent calcium imaging for TCR–pMHC interaction (Liu and Chen et 
al. in press). They have reported that in single-cell analysis calcium flux requires early 
and rapid accumulation of bond lifetimes whereas low calcium corresponds to high 
frequency of short lifetimes. Although the study is state of art, calcium is still in the late 
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stage of T cell signaling and many other proximal signaling activities are missing. In 
addition, how co-receptors contribute to the initiation of force-regulated TCR signaling is 
the key question that is not clearly answered. In addition to our force study, fluorescent-
based early signaling molecule study is necessary to answer these questions.  
 In an attempt to study the mechanism of co-receptor dependent catch-slip bonds, 
disrupting or blocking experiments can be conducted. We have conducted preliminary 
study with disrupting microfilament using latrunculin A on force-clamp assay. The data 
show that latrunculin A treatment reduces the bond lifetime somewhat but the overall 
trend holds for negative selecting ligands (Figure 7.1). Other cytoskeleton disrupting 
reagents such as blebbistatin (inhibitor for myosin II), or cholesterol depletion agent like 
methyl-β-cyclodextrin or cholesterol oxidase can be used to test its significance in force-
lifetime relationship. However, these attempts only show indirect evidence for the force-
regulated TCR characteristics. Alternatively, molecular dynamic simulation with protein 
structure could give more direct information on the mechanism. In these studies, force 
can be applied to TCR–pMHC–CD4/8 complex and important residues for rebinding or 
unbinding can be identified. Based on the simulation results, we can further reverse 
engineer mutate potentially critical residues and verify in experiments. In fact, 
unpublished data from colleagues (Liu et al.) show that force induces new interaction in 
TCR–pMHC interaction and also in CD4–MHC interaction. This result support that force 
may induce conformational change or reveal a cryptic site for a new stronger interaction. 





Figure 7.1: Latrunculin A treatment in force-lifetime relationshipLatrunculin A 
treatment lowered bond lifetime somewhat but the overall trend was consistent with no 
treatment. The sample size of bond lifetime for each ligand is listed as following: OVA 
(n=350), Q4 (n=129), Q4R7 (n=258), and VSV (n=110). 
 
 One of technical advancements in recent years is to manipulate DNA with single-
molecule fluorescence resonance energy transfer (smFRET) to measure single-molecule 
force in the order of pico newtons
116-118
. Recent single molecular force study show that 
cell apply ~40pN at single integrin-ligand peak tension and less than 12pN is required to 
activate Notch receptors
119
. This technique could be implemented to answer how much 
force is actually applied to TCR. It is possible with these DNA force probes that we can 
read forces being applied on the TCR in a cell culture environment. In addition, we can 
restrict the force field on the TCR–pMHC by designing the base pair of DNA for further 
studying force contribution in cellular function. Active study is undergoing with 
collaboration with Dr. Khalid Salaita’s lab in Emory University. 
 Our results indicated CD8-dependent synergistic TCR–pMHC–CD8 interaction is 
critical for negative selection. We have verified the findings with endogenous ligands and 
even in an alternative CD8 system. However, it will be interesting to study the 
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contribution of CD4 in thymic selection. From our CD4 study, we know that CD4 behave 
differently to CD8 with no cooperativity under zero-force. However, when force is 
applied CD4 also enhances the interaction of TCR–pMHC with agonist ligand. Kao et al. 
98
 previously reported that the antagonist peptide can mediate positive selection in the 
absence of CD4. How CD4 may contribute to thymic selection will be very interesting. 
Some studies have reported thymic selection study with APLs
120
 and endogenous 
ligands
121, 122
. Our preliminary force-lifetime assay on AND system show consistent 
findings with OT-I where catch-slip bond for negative selecting ligand MCC (red square) 
and slip bond for positive selecting ligand gp250 (blue triangle) (Figure 7.2). More 
thorough experiments are required. In addition, how force on TCR–pMHC interaction 
regulates “agonist selection” will be very interesting area for future studies.  
 
 
Figure 7.2: Force-lifetime analysis in AND systemPreliminary force-regulated bond 
lifetime data of TCR–pMHC–CD8 interaction in AND system with endogenous negative 
selecting ligand (MCC, red quare) and positive selecting ligand (gp250, blue triangle)
122
. 
The sample size of bond lifetime for each ligand is listed as following: MCC (n=57), and 
gp250 (n=13). 
 
 Our results in this thesis successfully identified physiologic characterization of in 
situ TCR–pMHC interaction with considering cellular membrane restrictions and 
physical force contribution to correlate with cellular function. Our findings highlight an 
important role of mechanical force in ligand discrimination and suggest a new 
 
 95 
mechanism for T activation and thymic selection that is distinct from previous models 
based on 3D measurements. This work has made a conceptual advance in the field since 
this is first study to show force-regulated TCR–pMHC–CD4/8 (trimolecular) bond 
lifetime correlates with T cell activation or thymic selection. The novel findings include 
measurement of CD4 contribution in TCR-pMHC binding under force, measurement of 
bond lifetime and stiffness for thymic TCR-pMHC interaction under force, measurement 
of signaling dependent thymic CD8 cooperativity and synergistic effect under force. 
 Although there was no single universal indictor for ligand discrimination, it seems 
like the discrimination mechanism can be affected at least by force level, co-receptor 
cooperativity, and maturation state. I believe this work has opened a new level of 
understanding for molecular base of T cell recognition.   
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